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STRUCTURAL ANALYSIS OF CYCLE INHIBITING
FACTOR FROM PATHOGENIC ESCHERICHIA COLI

Yun-Yuan Hsu, Ph.D.
The Rockefeller University 2008

Bacterial pathogens have evolved a sophisticated arsenal of virulence factors to
modulate host cell biology. Enteropathogenic and enterohemorrhagic Escherichia coli
(EPEC and EHEC) use a type III protein secretion system (T3SS) to inject microbial
proteins into host cells. These translocated proteins possess a diverse array of
biochemical activities, reprogramming eukaryotic cell biochemistry to serve the
requirements of the pathogen. Examples of translocated effector proteins hijacking
essential host functions such as cytoskeleton assembly, vesicular transport, and apoptosis
are numerous (Galan and Wolf-Watz, 2006). However, until recently, less progress had
been made with bacteria that also possess virulence mechanisms that target the host cell
cycle. Studies have demonstrated the capabilities of pathogenic bacteria in modulating
host-cell vital processes with a growing family of bacterial toxins and effectors that
interfere with the eukaryotic cell cycle (Nougayrede et al., 2005; Oswald et al., 2005).
The EPEC and EHEC T3SS effector Cycle inhibiting factor (Cif) is able to block
host eukaryotic cell cycle progression. We present here the crystal structure of Cif. It is
a divergent member of a superfamily of enzymes sharing a common Cys-His-Asp/Asn
catalytic triad, which includes cysteine proteases and acetyltransferases. Mutation of
these conserved active site residues abolishes the ability of Cif to block cell cycle

progression in different models. We demonstrate that Cif possesses auto-acetylation
activity that is dependent on a wild-type catalytic triad, whereas irreversible inhibitors of
cysteine protease activity do not affect the cytopathic phenotype. Finally, we identify the
cell cycle regulatory protein Nedd8 as an interaction partner for Cif. Cif binds Nedd8 in
vitro through both the catalytic domain and the N-terminal domain, the latter of which we
demonstrate to be absolutely required for Cif activity in the host cell.
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CHAPTER ONE:

INTRODUCTION

1.1 Foodborne illnesses

Foodborne illnesses are worldwide public health concern. They are generally
caused by consumption of food and water contaminated with bacteria, parasites, or
viruses. Their symptoms range from mild gastrointestinal distress to severe effects such
as diarrhea, vomiting, and fever. Globally, diarrheal diseases kill an estimated 2.1
million people, 1.8 million of those being children under age 5 (www.who.int). Diarrheal
diseases often occur in immune compromised individuals, the elderly, and infants. The
majority of foodborne illnesses are caused by pathogenic bacteria. The most common
bacterial foodborne pathogens are Campylobacter jejuni, Salmonella ssp, Escherichia
coli, Staphylococcus aureus, Listeria monocytogenes, Clostridium perfringens, Vibrio
parahaemolyticus, Vibrio vulnificus, and Shigella flexneri (Olsen et al., 2000). The
severity of symptoms caused by each pathogen varies from strain to strain.
Emerging health threats in industrialized countries are increasingly associated
with pathogenic Escherichia coli. Each year the United States alone reports about 76
million foodborne illnesses, resulting in 325,000 hospitalization and 5,000 deaths
(DuPont, 2007). The trend of diarrheal illnesses in industrialized nations is due to the
increase in transmission vessels of disease causing pathogens. Centralization of food
supply allows commercially available products to be mass distributed throughout the
country (DuPont, 2007). For example, in 2006 bagged spinach distributed for use in
1

salad was contaminated with E. coli. There were 199 people from 26 states infected and
three confirmed deaths with E. coli O157:H7 after the spinach consumption (CDC). This
incident demonstrated how contaminated food could be quickly spread from one location
to multiple regions around the county. The E. coli outbreak was not just a public health
concern, but it additionally had economic ramifications costing the food industry millions
of dollars (Lee, 2006).

1.2 Escherichia coli, commensal to pathogenic

Escherichia coli is a gram-negative, facultative anaerobic bacterium that
populates the gastrointestinal tract of warm-blooded animals. E. coli was first identified
in 1885 by the German pediatrician Theodor Escherich when he conducted a series of
experiments to study the impact of intestinal bacteria on the gastrointestinal tract
(Escherich, 1886). E. coli is the most widely studied and best understood bacterial
species. Its genome was fully sequenced in 1997 (Blattner et al., 1997). Commensal E.
coli is a member of the human intestinal microflora, providing the essential vitamin K2
(menaquinone) to its host organism (Bentley and Meganathan, 1982).
In 1945 John Bray and T.E.D Beavan recognized E. coli as a versatile
gastrointestinal pathogen after multiple occurrences of infant diarrheal outbreaks in the
United Kingdom. Bray isolated a strain of pathogenic E. coli that was absent in a healthy
individual’s stool (Bray, 1945). The ability for an E. coli strain to cause illness lies in its
genetic makeup. A conserved genomic sequence is common between the commensal and
pathogenic strains, allowing both to survive and colonize the host gut. In addition to a
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core genomic sequence, pathogenic E. coli strains contain multiple gene clusters acquired
through the integration of plasmids, bacteriophages, transposons, and horizontal gene
transfer of pathogenicity islands (PAIs) that enhance their ability to target and infect
specific tissues (Garmendia et al., 2005).
There are several virotypes of E. coli strains that have acquired the virulent
genetic elements, which allow them to cause a broad spectrum of diseases. These
pathogenic E. coli can cause intestinal diarrheal disease as well as extraintestinal disease
such as urinary tract infections and sepsis/meningitis. The enterovirulent E. coli is
further categorized into 6 subgroups:

enteropathogenic E. coli (EPEC),

enterohemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), enteroaggregative E.
coli (EAEC), enteroinvasive E. coli (EIEC), and diffusely adherent E. coli (DAEC)
(Kaper et al., 2004). They all have specific virulence attributes that allow them to
colonize sites apart from the lower bowel enterocytes.
Amongst the virotypes of E. coli, EPEC and EHEC contribute to most of the
foodborne illnesses. They cause acute gastroenteritis in humans. EPEC is a major cause
of infantile diarrhea in developing countries and malnutrition in the pediatric population
worldwide, killing close to 2 million children each year (www.who.int). EHEC causes a
wide spectrum of illnesses ranging from mild diarrhea to severe diseases such as
hemolytic uremic syndrome, which causes kidney failure and even death.

EHEC is

distinguished from EPEC by the production of Shiga toxin (Mainil et al., 1987). Shiga
toxin travels in the bloodstream from the colon to the kidney and damages renal
endothelial cells, eventually leading to hemolytic uremic syndrome (Obrig, 1997).

3

Once inside the human body, EPEC targets the small intestine, while EHEC
colonizes the colon (Kaper et al., 2004). They adhere to intestinal epithelial cells and
subvert cytoskeletal processes to produce a characteristic intestinal histopathological
feature known as ‘attaching and effacing’ (A/E) lesion (Moon et al., 1983). Bacteria
adhere to the enterocytes and modulate the host cell cytoskeleton by accumulating
polymerized actin beneath them. Microvilli are effaced, and pedestal-like structures arise
from the epithelial cells, where bacteria are intimately attached. Although they remain
extracellular, EPEC/EHEC are able to subvert host cell processes such as cytoskeletal
assembly, endocytic trafficking, and cell cycle progression, which results in bacteria
colonization of the mucosal site, evasion of host defenses, replication, and host cell
damage. E. coli’s ability to induce the A/E lesion and modulate host cellular processes
are attributed to its 35kB chromosomal pathogenicity island called the locus of enterocyte
effacement (LEE) (McDaniel et al., 1995) and the LEE-encoded multicomponent
organelle called the type III secretion system (Jarvis et al., 1995).

1.3 Type III secretion system
1.3.1 The apparatus

Many Gram-negative pathogenic bacteria utilize a complex system called the
Type III secretion system (T3SS) to mediate interaction with human, animal, and plant
hosts. E. coli’s T3SS is assembled from the products of approximately 20-25 genes from
the LEE pathogenicity island (Kaper, 1998). Electron microscopy studies show that the
T3SS is a syringe-like apparatus that resembles the flagellar hook-basal body complex
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(Kubori et al., 1998; Sekiya et al., 2001; Tamano et al., 2000). The T3SS apparatus is a
multiprotein complex that spans the inner and outer bacterial membrane and extends from
the surface forming a needle-like structure. T3SSs appear to have specifically evolved to
direct translocation of effector proteins from the bacterial to the host cell cytoplasm.
These effector proteins hijack host signal transduction pathways by mimicking host
cellular proteins (Galan and Collmer, 1999).
The T3SS needle complex is composed of two distinct parts: (i) a cylindrical
basal body that spans both the inner and outer membrane of the bacteria and (ii) a hollow
extracellular needle-like structure. The needle complex basal body is composed of three
parts: (i) an inner membrane ring, (ii) an outer membrane ring, and (iii) an inner-outer
ring connector. In E. coli, along with EscV as the main component, EscR, EscS, EscT,
and EscU constitute the inner membrane ring structure (Garmendia et al., 2005; Gauthier
et al., 2003). EscC is a homo-multimeric secretin that forms the outer membrane ring
structure and is involved in the transport of proteins across the outer membrane (Hueck,
1998). The lipoprotein EscJ in the periplasm connects the inner and outer membrane ring
structures (Crepin et al., 2005). The needle structure is composed of polymerized EscF
subunits (Wilson et al., 2001). Unique to EPEC/EHEC, the needle structure is extended
by the hollow EspA filament (Daniell et al., 2001b; Knutton et al., 1998; Sekiya et al.,
2001). The hollow tube formed by EspA has an outer diameter of 120 Å and a central
channel diameter of 25 Å (Daniell et al., 2003). The effector proteins are translocated
into the host cell through a pore in the plasma membrane formed by EspB and EspD via
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Figure 1.1: Schematic representation of the EHEC/EPEC type three secretion
system
The type III secretion system spans both the inner and outer bacterial membrane. The
secretin EscC multimerizes to form the outer membrane ring structure. The inner
membrane ring structure is constituted of EscR,S,T,U, and V. The lipoprotein EscJ
connects the outer to the inner membrane ring structures. The EscF polymerizes to form
the hollow needle structure. The EspA filament extends the needle structure. The EspB
and EspD create a pore in the host cell membrane and allow the EspA filament to
establish a connection between the bacterium and the host cell. In the bacterial
cytoplasmic side, the ATPase EscN provides energy to the system.
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the narrow channel of the EscF/EspA filament (Buttner and Bonas, 2002; Daniell et al.,
2003; Ide et al., 2001; Kresse et al., 1999; Lai et al., 1997). EspB and EspD have also
been speculated to function as the capping protein of the EspA filament (Daniell et al.,
2001a; Delahay et al., 1999; Fivaz and van der Goot, 1999; Hartland et al., 2000). On the
bacterial cytoplasmic side, an essential component of the T3SS is the ATPase EscN.
EscN resembles the catalytic β subunit of the F0F1-ATPases, sharing amino acid sequence
similarity and providing energy to the system (Dreyfus et al., 1993; Eichelberg et al.,
1994; Fan and Macnab, 1996; Woestyn et al., 1994) (Figure 1.1).

1.3.2 The chaperones

Type III secretion systems utilize a precise regulatory mechanism in directing the
translocation of a small number of effectors substrates to the host cell. Type III secretion
chaperones constitute a class of auxiliary proteins that are important for the efficient
translocation and secretion of the effectors. In the absence of chaperones, bacterial
cognate effectors are secreted less efficiently though the T3SS or not secreted at all.
T3SS chaperones are small, acidic homodimers that bind to N-terminal regions of one or
a few effectors at a time (Feldman and Cornelis, 2003). Although they have low amino
acid sequence similarity, recent studies have revealed structural homology between the
different chaperones (Lilic et al., 2006; Stebbins and Galan, 2003).

Five of the

EHEC/EPEC chaperones have been characterized thus far: CesAB, CesD, CesD2, CesF
and CesT. The chaperones bind to a specific effector in the bacterial cytosol and promote
the translocation of the effector while remaining in the bacterium.
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The T3SS chaperones act as stabilizing, anti-folding, and T3SS targeting factors.
First, chaperones have been shown to stabilize their cognate effectors in the bacterial
cytosol prior to secretion. For example, in Yersinia, the YopE effector is unstable and
rapidly degraded in the absence of its chaperone SycE (Frithz-Lindsten et al., 1995).
Given the secretion channel is between 2 to 3 nm and the size of effectors ranges from 15
to 80 kDa or more, the effectors must be in a non-globular state to be secreted (Blocker et
al., 2001; Kubori et al., 1998; Sekiya et al., 2001). Structural studies have shown that
chaperones keep their cognate effectors in an extended, non-globular conformation
(Birtalan et al., 2002; Phan et al., 2004; Schubot et al., 2005; Stebbins and Galan, 2001).
The chaperone maintains its effector in a secretion-competent state. Lastly, the targeting
of effector to the T3SS is highly governed by the chaperones. The chaperones direct the
effectors to the T3SS apparatus. The removal of an effector’s chaperone binding domain
inhibits secretion by the pathogenic T3SS, but not the flagellar T3SS (Lee and Galan,
2004; Lilic et al., 2006). In addition, the chaperones prevent the premature interaction
between effectors and the T3SS components (Woestyn et al., 1996).

1.3.3 The effector proteins

Pathogenic E. coli first adheres to epithelial cells through an unidentified adhesin.
The type III secretion system is subsequently activated to construct the needle complex
that injects the effector molecules into the host. Several effector molecules have been
identified and characterized. The LEE-encoded bacterial outer membrane protein,
intimin, facilitates the attachment of bacteria to the host cell (Frankel et al., 1994). It is
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exported to the periplasm by the general secretory pathway. The LEE-encoded type III
secreted protein Tir (transmembrane intimin receptor) is inserted into the host cell
membrane and serves as the receptor for intimin. Tir’s cytoplasmic domain is involved
in the recruitment of actin-rich pedestal structures beneath the adherent bacteria in a
Cdc42-independent manner (Kalman et al., 1999). The LEE-encoded effectors are Tir,
EspF, EspG, EspH, Map, SepZ, and EspB. Little is known about the role of EspH in
infection. It localizes to the host cell membrane and inhibits the formation of filopodia
while promotes the formation of actin pedestal (Tu et al., 2003). SepZ’s translocation is
not associated with a specific phenotype, and its function remains unknown (Kanack et
al., 2005).
Map, or mitochondrion-associated protein, affects mitochondrial function, causes
filopodia formation, disrupts intestinal barrier integrity, and alters tight junction structure
(Dean and Kenny, 2004; Kenny et al., 2002; Kenny and Jepson, 2000).

Once

translocated into the host cytoplasm, Map is targeted to mitochondria via its N-terminal
mitochondrial targeting sequence (Kenny and Jepson, 2000). Map disrupts mitochondrial
membrane potential, resulting in mitochondrial damage, and it mediates small GTPase
Cdc42-dependent filopodia formation, which in turn inhibit Tir-Intimin pedestal
formation (Kenny et al., 2002).
EspF causes apoptosis and induces redistribution of occludin, a tight junction
associated protein that disrupts the host intestinal barrier function (McNamara et al.,
2001). EspF contains a proline rich C-terminal region with three proline rich repeats in
EPEC and four in EHEC, indicative of a role in protein-protein interaction (McNamara
and Donnenberg, 1998; Viswanathan et al., 2004). Similar to Map, EspF contains N-
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terminal mitochondrial targeting sequence and plays a role in mitochondrial membrane
permeabilization. However, independent of mitochondrial targeting, Map and EspF
independently disrupt intestinal barrier integrity and are essential for intestinal barrier
dysfunction (Dean and Kenny, 2004). Map induces the release of cytochrome c from
mitochondria into the cytosol and the cleavage of caspase-9 and caspase-3, suggesting an
important role of EspF in triggering the mitochondrial death pathway (Nagai et al., 2005;
Nougayrede and Donnenberg, 2004).
EspG induces membrane ruffling through the destabilization of microtubules and
triggers actin stress fiber formation (Elliott et al., 2001). EspG is homologous to the
Shigella effector VirA and able to complement Shigella VirA mutants during infection.
VirA interacts with tubulin and helps trigger host microtubule destabilization (Elliott et
al., 2001; Yoshida et al., 2002). Similarly to VirA, EspG has been shown to interact with
tubulin and cause microtubule depolymerization, which consequently causes actin stress
fiber formation by an undefined mechanism (Hardwidge et al., 2005).
EspB is localized in both the host cell membrane and cytosol. In addition to
EspB’s role in the formation of the translocation pore and the capping of the EspA
filament, the cytosolic portion of EspB also modulates the host cytoskeleton by
interacting with α-catenin. The N-terminal region of EspB recruits α-catenin to the
EHEC/EPEC adherence site, and this interaction is important for A/E lesion formation.
Cells transfected with the N-terminal region or full-length EspB demonstrate a decrease
in F-actin accumulation at the site of bacterial adherence (Kodama et al., 2002; Wolff et
al., 1998).
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Several non-LEE-encoded effectors have been identified to be substrates of the
T3SS. There are four that have been characterized: Cif, EspI (NleA), EspFU/TccP, and
EspJ. These effectors are carried on small pathogenicity islets or prophages (Campellone
et al., 2004; Dahan et al., 2005; Garmendia et al., 2004; Marches et al., 2003; Mundy et
al., 2004b). EspI is encoded by prophage CP-933P (Chaudhuri et al., 2004) and colocalized with golgi (Gruenheid et al., 2004; Mundy et al., 2004a). Both EspFU/TccP
(Tir-cytoskeleton coupling protein) and EspJ are located in prophage CP-933U.
EspFU/TccP is a Nck-like protein that stimulates actin polymerization by activating NWASP in the presence of Arp2/3 (Garmendia et al., 2004). EspJ has been shown to
inhibit macrophage opsono-phagocytosis by both EHEC and EPEC (Marches et al.,
2008). Lastly, Cif (cycle inhibiting factor), a cyclomodulin, will be described in the next
section.

1.4 Cycle inhibiting factor

One substrate of the EPEC and EHEC T3SS has been shown to inhibit cell cycle
progression. The cycle inhibiting factor (Cif) is an effector protein encoded by a
lambdoid prophage that is incorporated into the bacterial genome (Marches et al., 2003);
Loukiadis et al., 2008). The 32 kDa Cif is a modular protein composed of an N-terminal
secretion and translocation signal and a C-terminal domain with effector activity in the
host cell (Charpentier and Oswald, 2004). Its chaperone has yet to be identified. Upon
translocation into the host cell, Cif induces a cytopathic effect (CPE) characterized by
cell cycle arrest at the G2/M transition associated with the formation of stress fibers and
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focal adhesion recruitment in HeLa cells and intestinal epithelial cells (Caco-2, IEC-6)
(Nougayrede et al., 2001; Taieb et al., 2006). The inhibition of stress fiber formation by
Rho inhibitors does not prevent accumulation of G2-arrested cells, implying that the cell
cycle inhibition induced by Cif is not a product of cytoskeletal alterations (Nougayrede et
al., 2001). Moreover, the lipid mediated delivery of purified Cif protein into HeLa cells
results in cells displaying CPE phenotype, suggesting Cif is necessary and sufficient for
the CPE (Taieb et al., 2006).
Some EHEC/EPEC strains have been identified to carry mutated cif with a
truncated C-terminus or no cif at all. For example, the prototype O157:H7 EHEC strain
does not contain cif. HeLa cells infected with strains lacking cif or carrying the cif Cterminal mutant (with the last 10 amino acids deleted) do not display Cif-induced
phenotype, which indicates that the last 10 amino acids are essential for Cif’s cytopathic
activity. When cif mutant strains are complemented with a cif-containing plasmid, they
are able to restore the Cif-induced phenotype in the host cell (Marches et al., 2003).
Although the cif gene is not present in all EHEC and EPEC strains, recent work has
revealed that the cif-encoding lambdoid prophage from E. coli E22 is capable of
propagating to new strains by lysogenic conversion in vitro (Loukiadis et al., 2008).
Interestingly, Cif-infected epithelial cells share phenotypic homologies to cells
treated with cytolethal distending toxin (CDT). CDT is a secreted tripartite holotoxin
composed of three subunits: CDT A, B, and C. CDT-B is the active subunit that is shown
to possess DNaseI activity and shares structural homology with DNaseI (Lara-Tejero and
Galan, 2000; Nesic et al., 2004; Stebbins, 2004). Both CDT and Cif-induced cell cycle
arrest occur with the sustained inhibitory phosphorylation of the mitosis inducer CDK1
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(Comayras et al., 1997; Cortes-Bratti et al., 1999; Marches et al., 2003; Whitehouse et al.,
1998). However, Cif has no sequence homology to CDT-B or DNaseI, and there is no
evidence that it can induce DNA double-strand breaks. Unlike CDT, Cif does not
activate the upstream effectors of the G2 checkpoint, the kinases ATM and ATR (Taieb et
al., 2006). Both ATM and ATR function in cell cycle checkpoint pathways activated by
DNA damage from double-strand breaks and DNA replication defects, respectively
(reviewed in (McGowan and Russell, 2004)). Therefore Cif is thought to hijack the
mitotic checkpoint without inducing DNA damage in an ATM/ATR independent
pathway. The Cif pathway leading to cell cycle inhibition remains to be elucidated.

1.5 Cell cycle regulation

The eukaryotic cell replication is an intricate process that is divided into four
distinct phases: gap phase 1 (G1), DNA synthesis (S), gap phase 2 (G2), and mitosis (M).
DNA is replicated in the S phase, and cell division occurs in the M phase. The S and M
phases are separated by G1 and G2. The G1 phase describes the period after cytokinesis
and before the S phase. The G2 phase occurs after the S phase and lasts until the cell
enters mitosis. The two gap phases serve an important function besides allowing the cells
to grow between the S and M phases; they monitor the external and internal environments
for suitable cell division conditions. The G1 checkpoint (or the restriction point) ensures
that the cell is large enough to divide with proper nutrients to support the daughter cells.
The G2 checkpoint verifies that DNA replication is complete and free of DNA damage.
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If the conditions are unfavorable, the G1/S and G2/M checkpoints will prevent cell cycle
progression at the specific point until the checkpoint requirements have been met.

1.5.1 Proteolysis in cell cycle regulation

Eukaryotic cells have evolved a complex control system that regulates the
progression through each stage of the cell cycle. The central components of this
regulation system consist of the cyclin-dependent protein kinases (Cdks). The activity of
Cdks is regulated by several mechanisms such as association with regulator cyclins,
interaction with Cdk inhibitors, phosphorylation and other post-translational
modifications (Sherr, 1996; Sherr and Roberts, 1999). The amount of Cdk regulators and
inhibitors oscillate at various stages of the cell cycle as a result of proteolysis (Murray,
2004). Most regulated proteolysis can be attributed to the ubiquitin-proteasome system.
The proteins are marked for degradation by ubiquitylation and then targeted to the 26S
proteasome complex (Pickart and Cohen, 2004; Weissman, 2001).
The ubiquitylation of a protein requires at least three enzymes: a ubiquitinactivating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a ubiquitin ligase (E3)
(reviewed in (Passmore and Barford, 2004)). Ubiquitin is activated at its COOHterminus via a thioester linkage to E1. Activated ubiquitin is then transferred to E2. E2
interacts with E3, whose function is to bring E2 and the substrate together (reviewed in
(Scheffner et al., 1995)). E2 can either transfer ubiquitin directly to the lysine residue of
the substrate, as in the case of the SCF complex (Deshaies, 1999), or it can transfer
ubiquitin to E3, as observed in the HECT-domain E3s (Kee et al., 2005). The E3
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components are primary responsible for substrate recognition. Two major types of E3
ligases are involved in cell cycle proteolysis: SCF (Skp1/Cullin/F-box protein) and
APC/C (anaphase-promoting complex or cyclosome) (Deshaies, 1999; Harper et al.,
2002; Murray, 2004; Nakayama et al., 2001; Seol et al., 1999). APC/C is activated
during mitosis and G1 to degrade proteins that impede mitotic progression and are
deleterious to G1 progression if accumulated (Bai et al., 1996; Cohen-Fix et al., 1996;
Funabiki et al., 1996; King et al., 1995; Sudakin et al., 1995). The SCF complex was
initially thought to be involved only in G1-S transition, but there has been increasing
evidence of the SCF complex involvement in other cell cycle phases (Bai et al., 1996;
Feldman et al., 1997; Skowyra et al., 1997).
The multisubunit SCF complex is comprised of the three invariable subunits
Skp1, Cullin-1 (Cul1), and RING H2 protein Rbx1 (also know as Roc1 or Hrt1) as well
as an interchangeable component, the F-box protein (Figure 1.2). Cul1 serves as the rigid
elongated scaffold that interacts with both Skp1 and Rbx1 subunits (Wu et al., 2003a;
Zheng et al., 2002b). Cul1’s N-terminus binds the Skp1 adaptor protein and the Cterminus binds Rbx1. Cul1 and Rbx1 form the catalytic core that recruits the to the SCF
complex. Skp1 is the adaptor protein that binds to different F-box proteins through the Fbox motif. The F-box protein is responsible for substrate recognition, and it orients the
substrate for ubiquitylation by E2 of the SCF complex. The SCF complex is able to
interact with a distinct set of substrates mainly due to the variable F-box proteins
(Cardozo and Pagano, 2004). Skp2 is a well-characterized F-box protein of the SCF
complex that participates in both G1-S and G2-M transition. Skp2 contains a binding site
that recognizes specific amino acid sequences of phosphorylated
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Figure 1.2: A depiction of the SCF complex with its substrate
The SCF complex has Cullin as its base. Cullin is a rigid elongated scaffold with Rbx1
attached to its C-terminal domain. Nedd8 is conjugated to a conserved lysine residue of
Cullin1. Nedd8 and Rbx1 assist the recruitment of E2 and ubiquitin. They also position
E2 in close proximity to the substrate. The F-box protein is anchored to the N-terminal
domain of Cullin1 via the adapter Skp1. The F-box protein recognizes the phosphorylated
substrate and orients the substrate to E2 for ubiquitylation.

substrates (Tsvetkov et al., 1999). SCF complex activation requires the covalent
conjugation of the small ubiquitin-like protein Nedd8 to the conserved lysine residue of
the Cul1 (Hori et al., 1999). The neddylation of Cul1 increases the E3 ligase activity
through Nedd8’s facilitated recruitment of the E2 (Furukawa et al., 2000; Morimoto et
al., 2000; Read et al., 2000; Wu et al., 2000) and the displacement of the SCF inhibitor
CAND1 (Liu et al., 2002; Zheng et al., 2002a).
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The SCF complex catalyzes polyubiquitylation of specific cell cycle regulators.
These polyubiquitylated proteins are immediately recognized and degraded by the 26S
proteasome. Removal of the cell cycle regulators triggers several critical events in the
cycle. For example, the Cdk inhibitors, p27 and p21, suppress G1/S-Cdk and S-Cdk
activities. Accumulation of the two proteins prevents cells from entering the S phase.
The SCF complex plays a crucial role in the degradation of the p27 and p21 to promoter
cell progression into S phase (Bornstein et al., 2003; Carrano et al., 1999; Sutterluty et
al., 1999; Tsvetkov et al., 1999; Yu et al., 1998). The SCF complex is involved in the G2
to M phase transition by acting on Wee1, a kinase that fine-tunes the Cdk activation
during entry to mitosis (Kellogg, 2003; Michael and Newport, 1998; Moshe et al., 2004).
Cdk1 must be dephosphorylated by Cdc25 phosphatases in order to promote entrance to
M phase. Wee1 has an inhibitory effect on Cdk1, therefore, inactivation of Wee1 shifts
the balance to Cdk1 dephosphorylation. The SCF complex’s effect is not limited to cell
cycle regulation. Approximately 70 F-box proteins have been identified, which provides
the SCF’s versatility targeting proteins outside of the cell cycle as well (Jin et al., 2004).

1.6 Aim of the thesis

Regulation of the eukaryotic cell cycle involves a complex meshwork of proteins
that instruct the cell to grow and replicate or to senesce. Cif is a T3SS cyclomodulin
from pathogenic Escherichia coli that is capable of deregulating the host’s cell cycle.
The mechanisms underlying Cif mediated cell cycle arrest and recruitment of focal
adhesions has yet to be established. Cif has no sequence homology to any known
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proteins. In order to elucidate Cif’s enzymatic mechanism during host cell infection,
structure-function studies of Cif were performed using x-ray crystallography in
combination with biochemical, cellular, and genetic assays. The structural investigation
of Cif could provide necessary information on its mechanism of action as well as shed
some light on the intricacies of cell cycle regulation. The first section of the thesis
describes Cif’s 3D structure and function.
identification of Cif’s host cell target.
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The subsequent part focuses on the

CHAPTER TWO:

MATERIALS AND METHODS

2.1 Mutagenesis of the putative catalytic triad

Amino acid substitutions were introduced into the cif gene by in vitro site-directed
mutagenesis using oligos containing specific base changes. The mutant plasmids were
amplified by PCR using Pfu Turbo DNA polymerase (Stratagene). The template plasmid
was removed by digestion with DpnI prior to transformation. The Cif full-length point
mutants were sequence verified and transformed into specified E. coli strains.

2.2 Infection assay

293T cells were synchronized at G1/S phase by double thymidine block
(O'Conner and Jackman, 1995). 293T cells were infected with E. coli strains transformed
with either wild type or mutant cif carrying plasmid at a multiplicity of infection (MOI)
of 100, under the arabinose inducible promoter. After 30 minutes post addition of the
bacteria to 293T, 0.2% of arabinose was added to the medium to induce Cif expression in
the bacteria. The bacterial infection stage required the medium to be free of FBS. 4
hours post infection, 293T cells were washed with 1X PBS, added with fresh DMEM
containing 10% FBS, 100µg/ml gentamycin (Gibco), and incubated for an additional 24
hours. 293T cells were harvested and fixed in 70% ethanol. The fixed cells were stained
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with propidium iodide and sorted by FACScalibur flow cytometer (BD Biosciences).
Data from at least 10,000 cells were analyzed by Cell Quest Pro (BD Biosciences).
The infection assay using HeLa cells was performed by Gregory Jubelin and Eric
Oswald as followed. Bacterial strains were cultured overnight in Luria-Bertani (LB)
broth then subcultured 1:100 in interaction medium (DMEM with 25mM Hepes and 5%
fetal calf serum (FCS)) for 3 hours at 37°C. HeLa cells (ATCC CCL-2), synchronized at
the G1/S phase transition by a double thymidine block (O'Conner and Jackman, 1995),
were washed and infected in interaction medium with MOI of 100:1. Following 90
minutes infection, the cells were washed and cultivated for the indicated times in DMEM
medium supplemented with 10% FCS and 200 µg/ml gentamicin.

2.3 Secretion Assay

Overnight static culture of transformed E. coli grown in DMEM was used to
inoculate DMEM at a ratio of 1:50. 0.2% arabinose was added to the medium to induce
the expression of Cif Flag tagged protein. The bacteria were grown for 6 hours at 37°C,
5% CO2, statically. The bacteria were spun down and the supernatant was passed though
a 0.45um filter. The type III translocated proteins in the supernatant were precipitated
with 10% trichloroacetic acid and then incubated on ice for 1 hour. The precipitated
proteins were washed twice with 100% acetone and resuspended in 3X SDS loading
buffer. The bacterial pellet fraction and the precipitated supernatant proteins were
separated by SDS-PAGE and analyzed by immunoblotting. Cif was detected by mouse
anti-Flag (Sigma).
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2.4 BioPORTER® assay

cif WT and point mutants were cloned into a modified pET21a vector and
transformed into BL21 (DE3). They were grown and purified using a Ni-NTA gravity
column (QIAGEN) in a similar method as pGEX4T3-Cif. The bacteria were lysed in
lysis buffer C (50mM Tris pH 8.0, 500mM NaCl, and 5mM imidazole pH 8.0), washed in
wash buffer C (50mM Tris, pH 8.0, 500mM NaCl, and 30mM imidazole, pH 8.0), and
eluted in elution buffer C (50mM Tris pH8.0, 500mM NaCl, and 250mM imidazole pH
8.0). Following the 3C removal of the hexahistidine tag, Cif was purified by Source 15Q
sepharose and Superdex 200 gel filtration chromatography. The purified Cif was
dialyzed into PBS. BioPORTER® (Genlantis) assays were performed by Gregory Jubelin
and Eric Oswald with purified Cif proteins (WT and mutants) as described previously
(Taieb et al., 2006). When indicated, E64 (Sigma) was used at 70µM and preincubated 10
min with purified Cif (WT or mutant) before mixing with BioPORTER®.

2.5 Stress fiber formation and cell cycle analysis

This section was performed by Gregory Jubelin and Eric Oswald. Study of cell
morphology and visualization of cytoskeleton was done as described (Taieb et al., 2006);
briefly, HeLa cells in chamber slides were fixed for 15 min in 4% formaldehyde,
permeabilized in 0.1% Triton X-100 and then incubated with rhodamine-phalloidin
(Molecular Probes) to stain F-actin and with DAPI (Sigma) to stain DNA. Images were
acquired with a DMRB fluorescence microscope equipped with a DFC300FX digital
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camera (Leica). Cell cycle distribution analyses were performed using a FACScalibur
flow cytometer (Becton Dickinson) as described previously (Sert et al., 1999). Data from
at least 10,000 cells were analyzed using FloJo software v8.5 (Tree Star).

2.6 In vitro protease assay

The BODIPY FL casein proteolytic assay was performed as suggested by the
manufacturer (Invitrogen). Five or ten micrograms of Cif, active site mutants, various Nterminal deletion mutants, and protease controls (papain and subtilisin) were added to
BODIPY FL casein and incubated at room temperature, protected from light, for at least
1 hour in a digestion buffer consisting of 10mM MES, pH 6.5. For the examination of
Cif loop mutant, Cif WT, loop mutant, and protease control papain were added to
BODIPY-FL casein in different pH. The detection of cleavage products was followed by
fluorescence (excitation/emission: 485/530nm). HeLa extract (200µg) was also included
in the assay buffer in some trials as indicated.

2.7 Auto-radiolabelling assay

Ten microgram of Cif WT or mutants was incubated with 2µl of 14C-acetyl-CoA
(50µCi/ml, GE Healthcare) and acetylation buffer (50mM Hepes pH 8.0, 10% glycerol,
1mM DTT, and 1mM PMSF) to a total volume of 30µl at 30°C for 1 hour. The reaction
was terminated by spotting the samples onto p81 filter papers (Millipore). The filter
papers were dried completely before washing 4 times with 125mL wash buffer (50mM
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NaHCO3/Na2CO3 pH 8.0) for 10 minutes. 4 mL of Readysafe® scintillation fluid was
added to the dried filter paper in a scintillation vial. The 14C-labeling was measured by
scintillation counting. 50-100µg of HeLa cell extract was included in some assays.

2.8 Acetyltransferase assays and mass spectrometry analysis

Each of the purified recombinant Cif WT (5mg, Cif1-282 theoretical molecular
weight 32122 Da), Cif C109S (5mg, Cif1-282-His theoretical molecular weight 33441
Da), and Cif triple mutant (C109S/H165A/D187A, 2mg, Cif1-282 theoretical molecular
weight 31995 Da) was incubated at 30°C for 60 minutes in acetylation buffer (20mM
Tris pH 8.0, 200mM NaCl, 2mM DTT, and 200µM acetyl-CoA (Sigma)). To check if
Nedd8 was modified by Cif, purified co-expressed Cif WT and Nedd8 complex (5mg
complex, Nedd8 theoretical molecular weight 9073 Da) was incubated at 30°C for 60
minutes in the acetylation buffer. The reaction was stopped by flash freezing the sample
in liquid nitrogen. Proteins were analyzed by electrospray ionization mass spectrometry
(ESMS). Briefly, samples were desalted using C-4 ZipTip (Millipore) and eluted from
the ZipTip using 50% acetonitrile/0.2% formic acid. The samples were introduced into a
Q-Tof Micro (Waters Corporation) using the nanospray technique. The data acquisition
and spectrum processing were performed using the MassLynx 4.0 software provided by
the manufacturer. 50-100 spectra were acquired and combined. The mass of the protein
was determined from the combined spectrum using the MaxEnt 1 algorithm and/or by
software, which calculated the mass after two multiply charged ions differing by one
charge were manually identified.
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2.9 Nedd8 binding assays

293T cells were transfected with pFLAG-CMV-Nedd8 using GenePORTER2
Transfection Reagent (Genlantis) following the manufacturer’s protocol. 48 hours post
transfection, 293T cells were lysed in RIPA buffer (50mM Tris pH 8.0, 250mM NaCl,
1.0% NP-40, 0.5% DOC, 0.1% SDS) in 3 freeze thaw cycles. Cif C109S was cloned into
the pGEX4T3 vector and expressed in BL21(D3E) cells. First, GST-Cif C109S was
purified from the bacterial lysate by glutathione sepharose (GE Healthcare). 100µg of
purified GST-Cif C109S was bound to pre-equilibrated Glutathione Sepharose 4B (GE
Healthcare) in equilibrating buffer (20mM Hepes pH 7.5, 5mM MgCl2, 100mM NaCl,
and 2mM DTT) at 4°C for an hour on a rotator. Either 100µg or 250µg of 293T lysate
was added to the GST-Cif C109S bounded glutathione beads and further incubated at 4°C
for 2 hours on a rotator. The glutathione beads were washed once with equilibrating
buffer, twice with wash buffer (20mM Hepes pH 7.5, 300mM NaCl, 5mM MgCl2, 0.1%
NP-40, and 2mM DTT), and lastly once with equilibrating buffer. 40µl of 3X SDS
loading buffer were added to the protein bound beads, and the beads were boiled at 95°C
for 5 minutes. The samples containing only the supernatant were separated by SDSPAGE and analyzed by immunoblotting. FLAG-Nedd8 was detected by mouse antiFLAG monoclonal antibody (Sigma).
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2.10 Bacterial co-expression of Cif and Nedd8

The nedd8 gene was subcloned from a plasmid containing the nedd8 full-length
cDNA clone (RZPD German Resource Center for Genome Research). cif 23-282 and
nedd8 were cloned into a modified CDFDuet-1 vector that contained two multiple
cloning sites (MCS) (Novagen). The MCS1 of the engineered CDFDuet-1 has an Nterminal hexahistidine with a 3C cleavage site that allows for N-terminal tag removal. cif
23-282 was cloned into the MCS1 (SalI, NotI), and nedd8 was cloned into MCS2
(HindIII, XhoI). pDuet-Cif23-282-Nedd8 was transformed into BL21(D3E) cells.
Cif23-282 and Nedd8 were expressed in a manner similar to pET21a-Cif100-282-His.
The bacteria were lysed by passage through an Emulsiflex-C5 (Avestin, Inc.).

His-

Cif23-282 and Nedd8 were co-purified by hexahistidine tag binding to chelating
sepharose and finally by gel filtration chromatography (buffer: 20mM Tris pH 8.0,
200mM NaCl, and 2mM DDT) and analyzed by SDS-PAGE. Both pDuet-Cif23-99Nedd8 and pDuet-Cif100-282-Nedd8 were purified similarly to that of pDuet-Cif23-282Nedd8.

2.11 Autoproteolysis assay

To test the AvrPphB activation model, 50µg of Cif WT or Cif C109S was
incubated with or without 5mM PMSF or 2µM E64 in buffer (20mM Tris pH 8.0,
200mM NaCl, and 2mM DT) for 12 hours at 37°C. The samples were analyzed by SDSPAGE and visualized by coomassie blue staining. To test the AvrRpt2 activation model,
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Cif WT, Cif C109S, and Cif 100-282 were tagged at both N- and C-termini with
hexahistidine. 2µg of Cif protein was incubated with 2µl of rabbit reticulocyte lysate
(Promega) or 200µg of yeast extract in 20mM Tris pH 8.0, 50mM NaCl, and 2mM
MgCl2 for 3 hours at 30°C. The samples were analyzed by immunoblotting using antiHis6-HRP (1:1,000, Sigma).

2.12 SDS-PAGE analysis and immunoblotting

Protein samples were boiled at 95°C in 3X SDS-PAGE loading dye. Samples
were separated by 15-18% SDS-PAGE gel. For immunoblotting analysis, the protein
bands were transferred from the SDS-PAGE gel to nitrocellulose membrane either
overnight at 60 milliamp or 1 hour at 100 volt in Tris-glycine buffer (25mM Tris, 190mM
glycine, 0.1% SDS, 20% methanol, pH 8.5). The membrane was first blocked with 1X
TBS-T (20mM Tris pH 8.0, 150mM NaCl, and 0.05% Tween-20) plus 5% milk for 30
minutes at room temperature and then washed 3 times, 10 minutes each with 1X TBS-T.
Primary antibody, diluted in 1X TBS-T plus 5% milk at the concentration suggested by
the manufacturer, was added to the membrane and incubated for 1 hour in room
temperature with shaking. The membrane was then washed 3 times with 1X TBS-T for
10 minutes each time. The secondary antibody was diluted in 1X TBS-T with 5% milk
and added to the membrane for 1 hour in room temperature. The membrane was washed
3 times with 1X TBS-T for 10 minutes each time. The ECL reagent (GE Healthcare) was
added to the membrane for signal detection.
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2.13 Purification of APPBP1/UBA3, Ubc12, Cullin-1/Rbx1, and Nedd8

Bacterial expression plasmids of Cullin-1/Rbx1, Ubc12, APPBP1/UBA3, and
Nedd8 were generous gifts from B. Schulman. Cullin-1 and Rbx1 were purified
according to experimental method described in (Li et al., 2005). APPBP1-UBA3 was
purified as described in (Huang and Schulman, 2005).
pGEX4T3-Ubc12 was grown and harvested in a similar method as the modified
pGEX4T3-Cif. GST-Ubc12 was first purified by glutathione sepharose gravity column
using the same method and reagents as GST-Cif purification. GST-Ubc12 did not bind to
glutathione sepharose efficiently, thus the flow through and wash fractions were reloaded
onto the column to maximize the yield. Thrombin (1:50 wt/wt) was added to GSTUbc12 for the GST tag removal and incubated for at least 16 hours at 4°C with buffer T
(50mM Tris pH 8.0, 200mM NaCl, 10mM DTT, and 5mM CaCl2). It was important to
dialyze out the glutathione due to its inhibitory effect on the thrombin cleavage. The
cleaved Ubc12 was diluted to 50mM NaCl and loaded onto Source 15S cationic
exchange chromatography to remove thrombin. Ubc12 and uncleaved GST-Ubc12
eluted into the flow through and wash fractions. These fractions were then loaded onto
Source 15Q anionic exchange chromatography. While the cleaved GST tag and GSTUbc12 bound to the column, the Ubc12 eluted into the flow through and wash fractions.
Ubc12 was further purified using gel filtration chromatography and stored in a buffer
containing 25mM Tris pH 8.0, 150mM NaCl, and 5mM DTT.
The mature conjugable Nedd8 (without the C-terminus following the Gly-Gly
dipeptide) was encoded in a pGEX4T3 plasmid. GST-Nedd8 was grown, harvested, and
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purified with a glutathione sepharose gravity column in a similar experimental protocol
as GST-Cif. GST-Nedd8 was diluted to 50mM NaCl from 200mM NaCl and loaded onto
Source 15Q anionic exchange chromatography. GST-Nedd8 was bound to the column
and then eluted with increasing salt concentration. Thrombin (1:100 wt/wt) was added to
GST-Nedd8 for the GST tag removal and incubated in the elution buffer with 5mM
CaCl2 at 4°C for at least 16 hours. The sample was further purified by gel filtration
chromatography. The sample eluted in two peaks, with one peak containing GST-Nedd8
and the other containing only Nedd8. Nedd8 was stored in 20mM Tris pH 8.0, 200mM
NaCl, and 2mM DTT buffer.

2.14 Reconstitution of Neddylated Cullin-1
For a 40µl reaction, 20ng APPBP1/UBA3, 10µg Ubc12, 80pmol (~8.14µg)
Cul1/Rbx1, and 15µg Nedd8 are incubated in the neddylation buffer (40mM Tris pH 7.5,
4mM ATP, 12mM MgCl2, and 50mM NaCl) at 37°C for 1 hour. 3X SDS-PAGE loading
dye was added to stop the reaction. To test if Cif could disrupt the E1’s or E2’s activity,
10µg of various Cif constructs and mutants were incubated with the reaction. The
samples were separated on a 4-20% Tris-HCL Ready Gel (Bio-Rad) then immunoblotted
with rabbit anti-Nedd8 (1:500, Alexis) or mouse anti-Nedd8 (1:5,000, Sigma). Cif crossreacted with rabbit anti-Nedd8.
To purify the neddylated Cul1/Rbx1 complex, the neddylation reaction was
purified by GST pulldown. The GST tag was attached to Rbx1. The neddylated
Cul1/Rbx1 complex was incubated with glutathione resin at 4°C, rotating for 1 hour in
equilibrating buffer (50mM Tris pH 8.0, 50mM NaCl, and 2mM DTT). The resin was
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washed twice with wash buffer (50mM Tris pH 8.0, 200mM NaCl, and 1mM DTT). The
elution buffer (50mM Tris pH 8.0, 50mM NaCl, 2mM DTT, and 5mM glutathione) was
added to GST-Rbx1/Cul1 bounded resin and incubated while rotating for 4 hours at 4°C.
The elution was dialyzed to remove the glutathione (buffer: 20mM Tris pH 8.0, 50mM
NaCl, and 1mM DTT) and stored at –80°C.

2.15 Deneddylation assay

Neddylated Cullin-1/Rbx1 was incubated with either purified Cif WT or Cif
C109S (20mM Tris pH 8.0, 50mM NaCl, and 1mM DTT) at 37°C for one hour. The
samples were separated by SDS-PAGE and analyzed by immunoblotting. Nedd8 was
detected by mouse anti-Nedd8 (Sigma).
Nedd8-AMC, Ubiquitin-AMC, or SUMO-AMC (BIOMOL International, LP) at a
concentration of 0.5µM was incubated with either 100nM of purified Cif WT, Cif C109S,
or various N-terminally truncated Cif in 120µM reaction buffer (50mM Hepes pH 7.5
and 1mM DTT) at room temperature, for 30 minutes in the dark. First the reaction buffer
was mixed with Cif before the AMC modified substrate was added to the mixture. The
samples were analyzed by spectrophotometer at excitation 380nm and emission 460nm at
1-minute interval for 30 minutes.
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CHAPTER THREE:

BIOCHEMISTRY AND CRYSTALLOGRAPHY OF
CIF

3.1 Cloning and protein expression
3.1.1 Non-template gene synthesis

The cif gene is only present in some EHEC or EPEC genomes, which are not
available commercially. Therefore, the 849 base pair long cif gene was initially
synthesized using assembly PCR (Stemmer et al., 1995). The method requires the
presence of a large number of overlapping oligodeoxyribonucleotides that, when
assembled, form templates for the gene of interest. The oligos are then subjected to
several rounds of PCR to assemble the full-length gene (Figure 3.1A).
The cif gene oligos were designed using a web-based algorithm DNAWorks.
DNAWorks has several user-defined parameters that allow the user to design a PCRbased gene according to specifications. In designing cif, the melting temperature of the
designed oligos was set to 58°C and the codon frequency was optimized for the E. coli
expression system. DNAWorks allows the user to input specific 5’ and 3’ flanking
sequences for directional cloning and to exclude specific restriction sites from the
synthesized gene. First, the program reverse translated Cif’s amino acid sequence into
nucleotide sequence. The sequence was then divided into sections and optimized to
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Figure 3.1: Non-template gene synthesis
(A) PCR assembly protocol for synthesis of the cif gene.
(1) 42 overlapping oligos, when assembled, form the template for cif.
(2) Gene Assembly: the oligos are mixed and subjected to 35 cycles of PCR.
(3) Gene Amplification: the PCR product from the gene assembly step is further
amplified with outer primers.
(4) The synthesized cif is digested with SalI and NotI and cloned into the vector of
choice.
(B) Gene assembly PCR. The 42 oligos were combined in a PCR mixture and subjected
to temperature gradient PCR reaction. The cif gene appears as a smeary band.
(C) Gene amplification PCR. The PCR products from the gene assembly step are
amplified with outer primers. The cif gene is shown as one distinct band.
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generate oligos that are highly homogeneous in melting temperatures, and the tendency
for hairpin formation was also minimized. The synthesized oligos were combined and
assembled using a two-step PCR method (Hoover and Lubkowski, 2002).
The cif gene having the same amino acid sequence found in EPEC and EHEC but
with a different DNA sequence was successfully synthesized by assembly PCR. A total
of 42 oligos, ranging in lengths from 32 to 51 bases, were generated. BamHI, HindIII,
NotI, and SalI restriction sites were specifically excluded from the DNA sequence for
future subcloning purposes. A SalI sequence was included in the 5’ flanking sequence,
and a NotI sequence was included in the 3’ flanking sequence. The mixed oligos were
diluted to 5 µM and subjected to the first round of PCR (gene assembly step). Various
DNA polymerases, PCR protocols, and PCR machines were tested before the gene was
successfully synthesized. The working combination required the BIO-RAD iCycler with
temperature gradient function. The reaction was carried out with one unit of high-fidelity
Taq polymerase (Invitrogen) and 0.2 mM dNTP (Fisher Scientific) with a temperature
gradient during the annealing step. The gene assembly’s PCR protocol is initiated with a
‘hot start’ step and 5 minutes of Taq activation at 95°C. This step was followed by 35
cycles of 30 seconds denaturation at 95°C, 30 seconds annealation with a temperature
gradient ranging from 50°C to 60°C, and 1.5 minutes DNA extension at 72°C. Lastly,
the PCR reaction was incubated at 72°C for 10 minutes. The PCR product from the gene
assembly step appears as smeared bands on the 1% agarose gel (Figure 3.1B).
Gene amplification occurs when outer primers are added to the gene assembly
PCR products and are subjected to a second round of PCR (Figure 3.1C). The PCR
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protocol for gene amplification was the same as for gene assembly, except the annealing
temperature was set to a uniform 58°C. The PCR product resulted in a single band on the
agarose gel. The cif full-length PCR product was purified from the gel and subcloned
into pCR2.1-TOPO vector (Invitrogen). The clones were sequence verified for the
DNAWorks-based cif sequence. cif was subcloned into modified E. coli expression
vectors pET21a (Novagen) and pGEX4T3 (GE Healthcare) using SalI and NotI sites and
then transformed into BL21(DE3) cells.

Engineered pET21a has an N-terminal

hexahistidine with a rhinovirus 3C protease site that allows for tag removal. The
modified pGEX4T3 has an engineered 3C cleavage site for glutathione S-transferase
(GST) removal and two hexahistidine tags at the N-terminus.

3.1.2 Protein expression and purification

Ten milliliter overnight cultures of the pGEX4T3-Cif full-length protein were
used to inoculate each liter of LB media (EMD Chemicals Inc) containing 100µg/ml
ampicillin. Cultures were grown at 37°C to an O.D600 of 0.8, then induced with 1mM
IPTG and grown for an additional 16 hours at 20°C. Bacterial cells were harvested and
resuspended in 10ml lysis buffer A (50mM Tris pH 8.0, 200mM NaCl, 10mM DTT,
1mM PMSF) per liter of original culture and then lysed using an Emulsiflux-C5
(Avestin). Immediately following lysis, 1mM PMSF was added to prevent proteolytic
digestion. To digest DNA and decrease viscosity, 0.1mg/ml DNaseI and 5mM MgCl2
were added to the lysate. After 10 minutes incubation on ice, 5mM EDTA was added to
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terminate the reaction. The lysate was spun at 16,000 rpm for 45 minutes in order to
separate soluble proteins, including Cif, from cell debris and inclusion bodies.
Cif was first purified using a glutathione sepharose gravity column (GE
Healthcare). The bacterial lysate was loaded onto the pre-equilibrated column (in lysis
buffer A), washed once with 5 column volumes of lysis buffer A and once with 5 column
volumes of wash buffer A (50mM Tris pH 8.0, 500mM NaCl, and 10mM DTT). The
protein was then eluted with 5 column volumes of elution buffer A (50mM Tris pH 8.0,
200mM NaCl, 10mM DTT, and 5mM glutathione). After the initial purification step, the
overall yield of GST-Cif was approximately 1 gram of protein per 2 liters of bacterial
culture. The protein sample was dialyzed into 3C digestion buffer (50mM Tris pH 8.0,
200mM NaCl, 5mM DTT, 1mM EDTA) and digested overnight with 3C protease at a 50
to 1 ratio (wt:wt) in order to remove the GST tag. Cif was further purified by anionic
exchange chromatography using a 25mL Source 15Q column (GE Healthcare) by FPLC
(Åkta). Cif was diluted to 100mM NaCl prior to column loading. Cif eluted off the
column at 200mM NaCl.

Fractions containing Cif were pooled together and

concentrated with Centricon-70 (Millipore) to 45mg/ml. In the final purification step, Cif
was injected onto a Superdex 75 gel filtration column and exchanged into crystallization
buffer (20mM Tris pH 8.0, 200mM NaCl, and 2mM DTT). The protein concentration
was measured by Bradford assay and visualized by coomassie staining on a 15% SDSPAGE gel.
To determine potential structural domains amenable for crystallization, various
Cif constructs were created based on secondary structure predictions and limited
proteolysis experiments. Using the PHD secondary structure prediction (Rost et al.,
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1994), Cif14-282, Cif57-282 and Cif66-282 were cloned into a modified pGEX4T3
vector and a modified pET21a vector. The purified Cif full-length protein was subjected
to limited proteolysis using the non-specific serine protease subtilisin. Subtilisin removes
flexible protein regions that may impair crystallization efforts. Subtilisin was added to
Cif at a 1 to 10% ratio (wt:wt) and incubated on ice for 20 minutes (Figure 3.2). The
reaction was initiated by 5mM CaCl2 and stopped with the addition of 100mM PMSF.
The digested samples were separated on a 15% SDS-PAGE gel and transferred onto a
PVDF membrane. Protein bands that persisted in the presence of increasing subtilisin
were sequenced by Edman degradation at The Rockefeller University Proteomics
Resource Center. The subtilisin digested products were identified as fragments starting at
residues 31, 93, and 100. Cif31-282, Cif93-282, and Cif100-282 were subcloned into a
modified pGEX4T3 vector and a modified pET21a vector.

All constructs were

transformed into BL21(DE3) cells (Table I).

Figure 3.2: Protease footprinting delineates the crystallizable Cif domain
Purified Cif1-282 was incubated with an increasing concentration of subtilisin at 4°C for
20 minutes. The fragments (boxed in red) persisted throughout the proteolytic digestion
of Cif. These samples were submitted for N-terminal sequencing and identified as
fragments starting at residues 31, 93, and 100.
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Table I: Cif constructs, solubility, purification yields and crystallization

Various Cif constructs were made based on PHD secondary structure prediction and
limited proteolysis. Cif100-282-His yielded well diffracted crystals.
As described in Chapter Two, the insoluble constructs were refolded to yield highly
soluble protein. Yield indicates quantity of Cif protein purified per liter of E. coli
culture broth. These data are a representative snap shot of a much larger number of
trials with constructs and variables.
N/A = crystallization experiment has not been performed for the given construct.
STLS = secretion and translocation signal (Charpentier and Oswald 2004).
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Crystallization trials were performed with the following constructs: Cif fulllength, 14-282, 31-282, 93-282-His, 100-282, and 100-282-His. Only Cif100-282-His
yielded well-diffracting crystals. pET21a-Cif100-282-His was grown at 37°C to O.D600
of 0.8 then induced with 1mM IPTG and grown for an additional 4 hours. The bacteria
were harvested and resuspended in 15ml lysis buffer B (8M urea, 10mM Tris pH 8.0, and
0.1M NaH2PO4•H2O) per liter of original culture. Cells were subsequently lysed by
sonication. Cif100-282-His was denatured under 8M urea. The lysate was spun at
16,000 rpm for 45 minutes to separate denatured protein from cell debris.

The

supernatant contained Cif. Cif100-282-His was purified using a nickel fast flow
chelating resin gravity column (GE Healthcare). The denatured protein was loaded onto
the pre-equilibrated column (in lysis buffer B), washed once with 5 column volumes of
lysis buffer B and once with 5 column volumes of wash buffer B (8M urea, 10mM Tris
pH 8.0, 0.1M NaH2PO4•H2O, and 30mM Imidazole pH 8.0). The protein was then eluted
with 5 column volumes of elution buffer B (8M urea, 10mM Tris pH 8.0, 0.1M
NaH2PO4•H2O, and 500mM Imidazole pH 8.0).
Cif100-282-His was refolded into the native state by gradual removal of the
denaturing agent through dialysis. Prior to refolding, Cif was diluted in lysis buffer B to
1.5mg/ml, which recovered approximately 95% of the refolded protein. The renaturation
step required a total of 4 buffer changes of 4L renaturation buffer (20mM Tris pH 8.0,
200mM NaCl, 5% glycerol, 2mM EDTA, and 5mM DTT) during 24 hours. The last
buffer exchange removes the glycerol from the renaturation buffer. 3C protease was then
added to the protein sample in a 1 to 50 ratio (wt:wt) in order to remove the N-terminal
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Figure 3.3: Cif 100-282-His gel filtration chromatography
Cif 100-282-His eluted as one peak on a Superdex 200 gel filtration column. The eluted
fractions were analyzed by SDS-PAGE gel electrophoresis and visualized by coomassie
staining as shown underneath the peak.

hexahistidine tag. Refolded Cif100-282-His was purified by anionic exchange and gel
filtration chromatography, as previously described (Figure 3.3).
In order to solve the crystal structure using single-wavelength anomalous
dispersion (SAD), seleno-methionine (SeMet) was incorporated into Cif. The Cif100282-His containing plasmid was transformed into the methionine auxotroph strain
834(DE3). An overnight culture in LB medium was grown and spun down. The
bacterial pellet was resuspended in minimal media with seleno-methionine and grown in
a shaker. When bacteria reached OD600 of 0.6, 100ml of bacteria was used to inoculate
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every liter of minimal media. Protein expression in bacteria was induced with 1mM
IPTG when OD600 reached 0.4. Lastly, the bacteria were grown for an additional 3.5
hours and then harvested. SeMet Cif100-282-His was purified and crystallized using the
same protocols as for the native Cif100-282-His protein. The purified and crystallized
His-tagged Cif protein was 22.4 kDa and began at residue Arg-100.

3.2 The crystallization and structure determination of the Cif protein

A random factorial sparse-matrix screen was used to methodically test over 2000
crystallization conditions for purified Cif100-282-His (25mg/ml). Cif crystals were first
observed in a 96-well sitting drop plate in Nextel’s Anionic Screen (QIAGEN). These
crystals were reproduced and optimized in 24-well plates using the hanging drop vapor
diffusion method and a 1:1 volume ratio of protein to well solution. All reagents and
proteins were equilibrated at 4°C prior to screening.

Crystallization trials were

performed on Cif100-282, in the absence of a C-terminal hexahistidine tag. It was
slightly less soluble than the His-tagged construct and did not crystallize under the same
experimental conditions.
Small rectangular shaped crystals of Cif100-282-His appear after 2 days at 4°C in
1.85-2.4M sodium malonate and 0.1M sodium acetate anhydrous pH 4.2-5.2 or trisodium citrate dihydrate pH 3.8. The native crystal used for data collection grew in
1.85M sodium malonate and tri-sodium citrate dihydrate pH 3.8. The SeMet crystal grew
in 1.85M sodium malonate and 0.1M anhydrous sodium acetate pH 5.0. Crystal
nucleation was mainly dependent on sodium malonate concentration; the increase in
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Figure 3.4: Cif 100-282-His crystal, diffraction pattern, and electron density
(A) Cif 100-282-His crystal. The Cif100-282-His crystal appeared after 2 days and grew
to full size in 2-3 weeks at 4°C. The crystal grew in 1.85M sodium malonate and 0.1M
tri-sodium-citrate dihydrate pH 3.8.
(B) The native Cif protein diffracts to 1.7Å.
(C) The 2.0 Å resolution of 2Fo-Fc electron density map (1.3σ contour level) from singlewavelength anomalous diffraction (SAD) phasing using Solve/Resolve with the final
model superimposed.
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concentration resulted in greater nucleation. Cif crystals grew up to 0.4mm in all
dimensions after 2 weeks. The crystals had sharp edges but were not very birefringent
(Figure 3.4A). Cif crystallized in the p4222 space group, with the unit cell parameters
a=b=111.515Å and c=106.808Å and angles α=β=γ=90°. There were two Cif molecules
per asymmetric unit.
Diffraction data for the native and SeMet Cif100-282-His crystals were collected
at X29 and X9A beamlines, respectively, at the National Synchrotron Light Source at
Brookhaven National Laboratories. The SeMet and native Cif crystals were soaked for
10 seconds in a cryoprotectant solution consisting of 2.6M sodium malonate pH 7.0.
The SeMet Cif crystal was flash-frozen at 100K by transferring into a gaseous nitrogen
stream on the site of collection. The native Cif was flash-frozen in liquid propane and
stored in liquid nitrogen before mounting on the goniometer. A fluorescence scan on the
SeMet Cif crystal was used to locate the peak wavelength for the selenium absorption
edge. The SeMet Cif data set was collected at the peak wavelength which maximizing
the anomalous signal. The SeMet Cif protein diffracted to 2.0Å, and native Cif diffracted
to 1.7Å (Figure 3.4B).
Data were processed with HKL2000 (Otwinowski and Minor., 1997). Phases
were determined by SAD using the program SOLVE, and improved by RESOLVE
(Terwilliger and Berendzen, 1999). SOLVE located a total of 10 selenium sites, with 5
from each of the two Cif molecules in the asymmetric unit. The initial model was
automatically built using Arp/Warp 6.1 (Morris et al., 2002; Perrakis et al., 1999;
Perrakis et al., 1997) and further refined using 1.7Å resolution data with REFMAC5
(Murshudov et al., 1997; Murshudov et al., 1999; Winn et al., 2001; Winn et al., 2003)
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Table II: Data collection and refinement statistics
Data Collection
Space group
Cell dimensions
a, c (Å)
Wavelength (Å)
Resolution (Å)
Rsym
I/sI
Completeness (%)
Redundancy

SeMet SAD

Native

P4222

P4222

111.515,
106.808
0.979
50-2.0 (2.072.00)
4.7 (17.3)
35.9 (12.7)
99.3 (100)
8.5

111.768,
107.518
1.000
50-1.70 (1.761.70)
4.5 (39)
28.7 (3.76)
98.86 (99.7)
4.7

Refinement
Resolution (Å)
No. reflections
Rwork / Rfree
Average B-factor
R.m.s deviations
Bond lengths (Å)
Bond angles (º)

50-1.70
70,819
0.172/0.209
26.6
0.02
1.710

Rsym = ∑h∑i | Ih,i - Ih | / ∑ h∑i Ih,i , for the intensity of i observations of reflection h. Rwork
= ∑ | FP - Fcalc | / ∑FP ; Fcalc = model structure factor and 5% data omitted for Rfree .
Bond and angle deviations are from ideal values; B-factor deviations are between bonded
atoms. The SeMet SAD data set was used for phasing, and the structure was
subsequently refined to 1.7Å resolution using the Native data set. Values in parentheses
are for the highest resolution shell.
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Figure 3.5: Cif Ramachandran Plot
Cif100-282-His Ramachandran plot is generated by PROCHECK (Laskowski et al.,
1993).
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from the CCP4 suite of programs (1994; Potterton et al., 2003; Saff, 1997) (Figure 3.4C).
The final model was completed through iterative cycles of manual building with the
program O (Jones et al., 1991) and refinement with REFMAC5 (Table II). Images were
generated using Pymol (DeLano, 2002), Swiss-PdbViewer (Guex and Peitsch, 1997), and
PDB Sum (EMBL-EBI). The Rwork/Rfree values of the final model are 17.2% and 20.9%,
respectively. The average B-factor value is 26.6%. Out of 334 residues, PROCHECK
(Laskowski et al., 1993) identified 95.2% of residues are in the most favored regions.
4.2% of residues are in the additionally allowed regions, and 0.6% of residues are in the
generously allowed regions (Figure 3.5). The overall G-factor is 0.11. The contact and
buried interface area of the two Cif molecules in the asymmetric unit were calculated
with the CCP4 suite programs AREAIMOL and CONTACT (Lee and Richards, 1971;
Saff, 1997).

The first seven residues (100-106) and the last five histidines from the

hexahistidine tag were not visible in the electron density map and therefore were omitted
from the model.
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CHAPTER FOUR:

CIF STRUCTURAL ANALYSIS

4.1 Overall structure of Cif

Cif(100-282) consists of a single domain with a mixed α/β fold. Cif has a central,
four-stranded anti-parallel β-sheet, with a B4, B1, B2, B3 topology, surrounded on both
sides by six α-helices (H1-H6) and connecting loops (Figure 4.1A). The B1-B3 βstrands are continuous in sequence and are connected by short turns. B4 is separated
from B3 by helices H3-H5 and lies parallel to the B1 β-strand. The N-terminus of the
crystallized construct (starting with Proline 107) forms an α-helix (H1) that packs with its
axis nearly parallel to the strands in the β-sheet. The C-terminal helix (H6) points away
from the core. The β-sheet is sandwiched by the α-helices with H1 and H6 at one side
and H2-H5 on the other.
Two Cif molecules are present as a dimer in the asymmetric unit of the crystal
(Figure 4.2A), forming an interface that buries approximately 318Å2. This proteinprotein interface is mainly comprised of N-terminal (residues 107-129) and C-terminal
(residues 270-288) regions of one Cif molecule with the corresponding regions of the
second Cif molecule. The dimer interface has a total of 4 hydrogen bonds and 119
hydrophobic/van der Waals contacts (Figure 4.2B). One hydrogen bond is found in the
C-terminal region and three in the loop following the N-terminal helix.

The protein-

protein interface at the C-terminal region involves Cif’s C-terminal helix H6 as well as
the linker residues (GAAALE)
45

Figure 4.1: Overall structure of Cif
(A) A ribbon diagram of a Cif100-282-His monomer.
(B) Sequence and secondary structure of Cif100-282-His. The putative catalytic triad
residues are highlighted in yellow. Figure generated by PDB Sum (EMBL-EBI)
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Figure 4.2: Structure of two Cif molecules
(A) Two Cif molecules in the asymmetric unit shown as ribbon diagram.
(B) The contact interface residues between the N- and C-termini in two Cif molecules of
the asymmetric unit. The orange dashed lines represent non-bonded contacts, and the
blue solid lines represent hydrogen bonds. Figure generated by PDB Sum (EMBL-EBI).
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between Cif and the first histidine of the hexahistidine tag. This region is ordered and
participates in dimer formation. The linker residue Ala286 from Molecule A hydrogen
bonds to the phenol group hydroxyl of Tyr184 from Molecule B. The C-terminal helix
from the first Cif monomer lies against the C-terminal helix of the second Cif molecule
(Figure B). The second area of dimer interaction is found in the loop residues 122-129 of
both Cif molecules. The side chain oxygen atom of Ser127 forms a hydrogen bond with
the main chain NH group of Tyr128 in each monomer. The third hydrogen bond found in
the N-terminal region is between the side-chain amine nitrogen (NZ) of Lys118 from
Molecule A to the carboxylate oxygen atom (OD2) of Asp122 from Molecule B.
The observed Cif dimerization could be attributed to a crystal packing artifact or
to the protein-protein interactions in the C-terminal α-helix and the N-terminal region.
Since Cif’s C-terminal helix is essential for activity, its functional role could be to bring
two Cif molecules together as a dimer. Probing how this helix contributes to protein
solubility and dimer formation could yield interesting functional information.
Experiments are described in Chapter Five.

4.2 Cif is a structural member of the cysteine protease superfamily

A search of known structures in the Protein Data Bank revealed that Cif shares
structural homology to Pseudomonas syringae AvrPphB (PDB ID code 1ukf) with a Zscore of 4.0 and root-mean-square deviation (RMSD) of 3.8 over 88 residues (Holm and
Sander, 1995) (Table III). However, the proteins bear no sequence similarity. AvrPphB
is a member of an enzyme superfamily of that consists of cysteine proteases,
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acetyltransferases, and transglutaminases (Andreeva et al., 2004).

While there is

considerable divergence across this superfamily in the overall fold, an anti-parallel βsheet along with an N-terminal helix which packs against the β-strands, are conserved
(Rawlings and Barrett, 1994) (Figure 4.3). The catalytic core fold of Cif also closely
follows the topology of other members of the cysteine protease superfamily. The
conserved fold in Cif begins at its N-terminal helix (H1) and includes the central four βstrands (with B4, B1, B2, and B3 linking topology). Several of the catalytic residues in
these proteins are located on these elements as discussed below.

Table III: Dali Result
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Cif’s structure is compared to two members of the cysteine protease superfamily
AvrPphB and arylamine N-acetyltransferase (NAT). AvrPphB, with its high Z-score and
low RMSD, exhibits the closest fold to Cif. It is categorized as a member of the papainfamily cysteine proteases or clan CA proteases. These cysteine proteases all have an
invariant catalytic triad consisting of cysteine, histidine, and aspartate/asparagine that is
essential for proteolytic activity (Barrett and Rawlings, 2001). The cysteine protease
AvrPphB is a T3SS avirulence protein from a plant pathogen P. syringae that triggers a
disease resistance response in its host plants (Mansfield et al., 1994). AvrPphB’s
catalytic triad consists of cysteine 98, histidine 212, and aspartate 227 (Shao et al., 2002).
Like other members of the cysteine protease superfamily, NAT has a protease-like
catalytic triad (Cys69-His107-Asp122) (Sinclair et al., 2000).

NAT catalyses the

acetylation of arylamines, hydrazines, and their N-hydroxylated metabolites by
transferring the acetyl group from acetyl-CoA to the terminal nitrogen group of the
substrate (Weber and Hein, 1985).
Initially, a potential catalytic triad (Cys109-His165-Asp187) was identified in the
Cif crystal structure based on the spatial proximity between these three residues and the
assumption that the third residue was either an aspartate or asparagine. Aligning this
putative catalytic triad with that of other members of the superfamily resulted in a poor
overall alignment in which the common core fold was misaligned (Figure 4.4A). When
the core fold of Cif and the members of superfamily are structurally aligned, the catalytic
triad of Cif is shifted by several angstroms. We then aligned only the side chains of
Cys109 and His165 with the corresponding catalytic cysteine and histidine from the
cysteine proteases (Figure 4.4B). This gave a far better structural alignment of the
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Figure 4.3: Structural comparison of Cif with cysteine protease superfamily
members
Upper panel: Ribbon diagrams of Cif, AvrPphB (PDB ID code 1ukf), and NAT (PDB
ID code 1e2t). The catalytic triad in the active site is rendered as a stick model. The
structurally conserved α-helix is colored green, and the β-sheets are colored orange.
Lower panel: Topology diagrams of the listed proteins. The catalytic triad residues of
each protein are depicted as red circles.
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Figure 4.4: Structural comparison of Cif’s proposed catalytic triads
(A) Superposition of the catalytic triads of Cif (grey), AvrPphB (red), and NAT (blue).
Left panel: superposition using Cif Cys-His-Gln. Right panel: superposition using Cif
Cys-His-Asp.
(B) The alignments of the catalytic cores of Cif (grey), AvrPphB (red), and NAT (blue)
using two different putative Cif catalytic triad. The catalytic cores are rendered as cartoon
loops with the catalytic triad residues in sticks. Left panel: Cif Cys-His-Gln as the
reference. Right panel: Cif Cys-His-Asp as the reference.
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common core, but Asp187 no longer aligned with the Asp/Asn of the other catalytic
triads. However, glutamine 185 did; it falls in proximity to the Asp/Asn of the other
proteins. In fact, the distance between bonding element in this alignment is more similar
to other catalytic triads than with the Asp alignment (Figure 4.5). The amide oxygen
(OE1) of Gln185 forms a hydrogen bond (2.81Å) with the protonated (ND1) side chain
of His165, keeping the imidazolium ring in a favorable orientation in a very similar
fashion to papain, staphopain, and AvrPphB (Shao et al., 2002). The distance between
NE2 of His165 and SG of Cys109 averages 3.72Å, which corresponds to the distance
observed in other members of the cysteine protease superfamily (Shao et al., 2002).

Figure 4.5: The bonding distances between Cif’s catalytic residues
Cif’s Cys-His-Gln catalytic triad is compared to AvrPphB/NAT’s catalytic Cys-His-Asp
and papain /staphopain’s catalytic Cys-His-Asn. The amide oxygen (OE1) of Gln185
forms a hydrogen bond (2.81Å) with the protonated (ND1) side chain of His165. The
distance between NE2 of His165 and SG of Cys109 averages 3.72A, which agrees well
with other members of the cysteine protease superfamily.
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In comparing the residues present at the molecular surface of Cif with those of
other members of the cysteine protease superfamily (AvrPphB and NAT), it is observed
that all three proteins have solvent exposed catalytic cysteine and histidine residues
(Figure 4.6B). In AvrPphB and NAT, the catalytic aspartate is buried. Cif Asp187 is
solvent exposed while Gln185 is buried, providing further supporting evidence for
Gln185 being the likely third catalytic residue as opposed to Asp187. Although there is
no predecessor for a glutamine acting as the third catalytic residue in cysteine proteases,
our structural analysis suggests that Cif’s Gln185 is indeed part of the catalytic triad.
In Cif, the nucleophile, Cys109, is located on the N-terminus of α-helix H1 and
His165 is located on the N-terminus end of the B2 β-strand. The third catalytic residue
Gln185 lies on the C-terminal end of the B3 β-strand. The relative positioning of the
catalytic residues in AvrPphB and NAT is similar to that of Cif. The catalytic cysteine
residue of both AvrPphB and NAT lies on the N-terminus of a helix positioned similarly
with respect to the β-sheet as the helix H1 of Cif. The histidine residue is located on a βstrand, and the aspartate residue is positioned on or close to the β-strand. Like other
papain-like cysteine proteases, Cif’s β-sheet and the packing α-helix are separated by a
groove containing the active site formed by residues Cys109 and His165, which are on
either side of the active site cleft. We could not locate in Cif the Asn/Gln residue that
could participate in the formation of a catalytically active structure known as the
oxyanion hole. The oxyanion hole is an important feature in the cysteine protease active
site that stabilizes the main-chain carbonyl group of the P1 residue of the substrate.
Generally the oxyanion hole is formed by the main-chain amide of the catalytic cysteine
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Figure 4.6: The Cif active site is occluded relative to other members of the cysteine
protease superfamily
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Figure 4.6: The Cif active site is occluded relative to other members of the cysteine
protease superfamily
(A) The catalytic triad of Cif, with the occluding loop shown in magenta that blocks part
of the active site.
(B) Molecular surface representation of Cif, AvrPphB, and NAT. The catalytic triad
residues are colored as following: cysteine in yellow, histidine in blue, and aspartate in
red. In Cif CHQ (loop out), in silico removal of the occluding loop (residues 189-195)
creates an extensive cleft, reminiscent of the substrate binding grooves of AvrPphB and
NAT. Cif CHQ is where Cif has cysteine, histidine, and glutamine as its putative
catalytic triad residues. Cif CHD has cysteine, histidine, and aspartate as its putative
catalytic triad residues.
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and by the side-chain amide of the glutamine or asparagines residue (Rawlings et al.,
2006). Based on the putative catalytic triad orientation, the oxyanion hole Asn/Gln
residue would likely lie before proline 107, which is located outside of the visible
electron density.
Cif’s putative catalytic triad can be superimposed well with the catalytic triad of
AvrPphB (Zhu et al., 2004), other cysteine proteases such as papain (PDB ID code 1ppn)
(Kamphuis et al., 1984) staphopain (PDB ID code 1cv8) (Hofmann, 1993), and NAT
from Salmonella enterica serovar Typhimurium (PDB ID code 1e2t) (Figure 4.4)
(Sinclair et al., 2000). Such alignment yields an aligned common core, which further
defines the structural homology between the cysteine protease superfamily.
A unique structural feature of Cif relative to other superfamily members is the
presence of an occluding loop situated near the active site (Figure 4.6A). The occluding
loop (residues 189-195) obstructs part of the active site, generating a narrow proteinbinding cleft (Figure 4.6B). As a consequence, the loop possibly restricts active site
accessibility to a polypeptide substrate. Such an occluding loop feature is not present in
the structure of AvrPphB or NAT. These two proteins possess deep and extended
substrate binding clefts. To visualize Cif without the occluding loop, we generated an
image of Cif with the loop residues 189-195 deleted. As shown in Figure 4.6B, the
removal of the loop created a deeper catalytic cleft, which would allow the substrate to
bind more efficiently. The biological relevance of Cif’s occluding loop is unknown.
Whether substrate or co-factor binding would displace the loop or the loop acts as an “onoff” switch needs further investigation.
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CHAPTER FIVE:

EXPERIMENTAL RESULTS BASED ON
STRUCTURAL ANALYSIS OF CIF

5.1 C-terminal helix structural analysis

E. coli strains carrying mutations in the last 10 amino acids of Cif do not cause
cytopathic effect in infected cultured cells. In the crystal structure, both the N- and Cterminal helices of Cif contribute substantially to dimer contacts by interacting with the
corresponding helix in the second Cif molecule. As the C-terminal helix was previously
shown to be essential for Cif activity (Marches et al., 2003; Charpentier and Oswald,
2004), this raises the possibility that its functional role could be to form an active dimer.
To elucidate the biological relevance of Cif’s C-terminal helix, two C-terminal truncated
variants were constructed: (i) Cif1-265, which has its C-terminal helix completely
deleted; and (ii) Cif1-272, which has the last 10 amino acids deleted, based on prior work
demonstrating their importance for Cif’s activity (Marches et al., 2003). Their solubility
and gel filtration profiles were examined.
Both Cif1-272 and Cif1-265 were insoluble and had to be denatured, refolded,
and purified under the same conditions as Cif100-282-His (Chapter Two). Cif 1-272 and
Cif1-265 were loaded on to Superdex200 size exclusion column. The gel filtration
profiles of the C-terminal truncated Cif proteins were compared to that of refolded Cif
full-length construct under low salt buffer conditions (20mM Tris pH 8.0, 50mM NaCl,
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and 2mM DTT) (Figure 5.1A,B).

Experimental molecular weights (MW) were

calculated based on a standard calibration curve. Under low salt conditions, Cif1-282
exhibited the properties of a dimer having an experimental MW of 69KD that was
approximately double the size of a monomer’s theoretical MW (32KD). However, these
data do not exclude the possibility that Cif1-282 elutes as an elongated monomer. Based
on their elution profiles, both Cif1-272 and Cif1-265 mutants appeared to be either highly
elongated (Stroke’s radius of 2.28 and 1.86, respectively) or they could also exist as
higher molecular weight aggregates. The Cif N-terminus could possibly contribute to the
elongation or oligomerization of Cif1-282 and the Cif C-terminal truncated mutants.
Thus, a mutant with an N-terminal truncation, Cif100-282-His (the crystallized
construct), was tested. Similar gel filtration characteristics between Cif100-282-His and
Cif1-282 were found (Figure 5.1C,D). Under low salt conditions, refolded Cif100-282His ran at an experimental MW of 54.9 KD which is approximately twice that of a
monomer’s theoretical MW (22KD). The dimerization of Cif could also be due to low
ionic strength. Various Cif constructs were tested in high salt buffer conditions (20mM
Tris pH 8.0, 200mM NaCl, and 2mM DTT). Cif1-282 and Cif100-282-His ran as
monomer with an experimental MW of 39KD and 31.3KD respectively. Nevertheless,
the C-terminal mutants both ran twice the size of their monomeric MW with Cif1-265 at
61.6KD and Cif1-272 at 58.7KD (Figure 5.1B).
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Figure 5.1: Gel filtration profiles of Cif and deletion mutants in different salt
concentrations
The gel filtration profiles of Cif C-terminal deletion mutants in (A) 50mM and (B)
200mM salt concentration. Cif full-length and crystallized construct Cif(100-282)His gel
filtration profile in (C) 50mM and (D) 200mM salt concentration. Cif and various
standard marker proteins were run on Superdex 200 gel filtration column using an AKTA
FPLC. A standard calibration curve based on the standard markers’ elution volumes was
used to determine the experimental molecular weights of Cif. The calculated molecular
weights of globular proteins based on the elution volume are indicated in parentheses.
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Gel filtration chromatography experiments indicated that both the full-length and
the crystallized construct of Cif exhibited properties of a dimer but only in low salt
conditions (Figure 5.1A). The C-terminal mutants were insoluble and following
refolding, ran as higher molecular weight aggregates on size exclusion chromatography
(Figure 5.1A). These data confirm the truncations in the C-terminus greatly affect the
solubility and folding of the protein (Charpentier and Oswald, 2004) but do not clarify its
role in dimer formation. Since dimer formation occurs only in crystallo or in low salt
conditions, it is quite possible that the biologically relevant state of Cif is monomeric.

5.2 Analysis of catalytic triad mutations in Cif
5.2.1 Mutagenesis of the catalytic triad and infection assays

Based on structural analysis, Cif contains a putative catalytic triad consisting of
Cys109, His165, and Gln185 or Asp187. To test whether these residues were critical to
Cif’s function, point mutations were constructed by site-directed mutagenesis of the
native Cif and evaluated in an infection assay.

Pathogenic E. coli strains with mutated

cif or lacking the cif gene were complemented with cif wild type and cif mutant carrying
plasmids to probe whether cell cycle arrest and enlargement of HeLa cells are induced.
EDL-933 and ED-31 are the two human EHEC strains, and C712-65 is a human
EPEC strain. EDL-933 is the serotype O157:H7 without the cif gene in its genome. ED31 belongs to serogroup O111 and carries a truncated, nonfunctional cif (Marches et al.,
2003). C712-65 is the serotype O125:H6 that was not previously examined for cif’s
presence. All three strains’ genomic DNA were isolated and sequenced for cif gene
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presence. EDL-933 and ED-31 did not have the full-length cif gene and agreed with
Marches et al’s data. C712-65 does contain the functional cif gene. C712-65 was shown
to induce cell cycle arrest at the G2/M phase in infected cells.
E. coli strains EDL-933 and ED-31 were transformed via electroporation with an
arabinose-inducible vector carrying either C-terminal flag epitope tagged Cif wild type or
Cif point mutants (C109S, H165A, Q185, or D187A). These transformed strains were
used to infect G1/S synchronized 293T cells. 293T cells were synchronized at G1/S phase
by the double thymidine block (O’Connor et al., 1995). Cells infected with the Cif point
mutant C109S and H165A had similar DNA-content profiles as the E. coli strains that
carried either a non-functional Cif or Cif-null. On the other hand, Cif WT infected cells
were arrested at the G2/M phase of the cell cycle (Figure 5.2A). Though the D187 mutant
in our analysis initially appeared to be non-functional, later experiments reveal that this
point mutant is partially active. Mutations of Cif Q185 were not tested in the infection
assay due to the protein’s poor solubility in the bacterial recombinant protein expression
system. Cif Q185 mutant would likely not be folded properly in the pathogenic bacteria
due to its insolubility and not be translocated through the T3SS. Despite many efforts at
substituting of Q185 for leucine, alanine, serine, asparagine, glutamate, and glycine, point
mutations at this residue disrupted the folding of the protein. As shown in the molecular
surface representation of Cif (Figure 4.6B), Q185 is buried in the interior of the protein.
Mutation of this residue could highly compromise the protein’s integrity, resulting in
improper folding.
The infection assay was further refined using EPEC strain E22 mutated for cif.
HeLa cells were infected with EPEC_cif mutant expressing plasmid-encoded Cif WT or
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Cif mutants. As expected, Cif WT caused enlargement of cells, actin stress fibers
formation, and cell cycle arrest at the G2/M phase transition (Figure 5.2B). In contrast,
cells infected with EPEC_cif expressing C109S or H165A mutants behaved like the
control cells (Figure 5.2B), indicating that these residues are critical for Cif activity
and/or translocation. In contrast, the EPEC_cif expressing D187A mutant revealed a
partial effect, characterized by a heterogeneous monolayer including both enlarged cells
harboring actin stress fibers and unaltered cells still cycling as evidenced by the presence
of mitotic figures (Figure 5.2B). This partial effect was confirmed by FACS analysis of
the DNA-content of infected cells. In cells infected with EPEC_cif expressing Cif
D187A, the percentage of cells with 4N DNA-content (G2-arrested) increased up to 40%
compared to 18%, 15% and 14% found in control cells or cells infected with EPEC_cif
expressing Cif C109S or Cif H165A respectively, but remained lower than that induced
by Cif WT (40% with Cif D187A and 57% with Cif WT).

5.2.2 Cif point mutants solubility and translocation

To check whether the absence or reduced activity of the catalytic triad mutants
was due to poor protein expression or solubility, the strains were treated to activate T3SS
and examined for protein expression and secretion as described in Chapter Two. We
showed that Cif WT, C109S, and D187A were expressed and secreted from bacteria into
the medium by immunoblotting detection. H165A was poorly expressed in bacteria,
which suggesting the histidine mutant is unstable (Figure 5.3A).
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Figure 5.2: The cysteine and histidine residues of Cif catalytic triad are critical for
stress fiber formation and cell cycle arrest
(A) 293T cells were synchronized at G1/S phase by double thymidine block and were
infected for 4 hours. Cell cycle analysis by flow cytometery of propidium iodide stained
293T cells was performed 24 hours post-infection.
(B) Cell cycle distribution analyses of HeLa cells infected with E22Δcif complemented
with plasmid carrying either Cif WT or catalytic triad mutants. Upper panels: F-actin
was labeled with phalloidin-rhodamine (red) and DNA with DAPI (blue) 72h postinfection. Bars correspond to 50 µm. Lower panels: cell cycle distribution according to
DNA-content was analyzed by flow cytometry 48h post-infection. Percentages of 2N
and 4N populations are indicated. These experiments were performed by Gregory
Jubelin and Eric Oswald.
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However, our secretion assay did not distinguish between flagellum secreted
protein and the T3SS specific translocated proteins. We monitored the injection of the
Cif mutated forms using the TEM1 β-lactamase fusion assay (Charpentier and Oswald,
2004). Wild type Cif and its mutants were fused with TEM1 β-lactamase and expressed
in EPEC_cif strain. Translocation levels were determined by adding CCF2 as a substrate
for the intracellular TEM-1 β-lactamase and by immunoblotting. All three point mutants
were translocated but each to a different degree. The C109S mutant was translocated at a
level similar to that of Cif WT (Figure 5.3B). In contrast, the D187A and H165A
mutants were translocated into infected HeLa cells with less efficiency. We observed a
two-fold and a ten-fold reduction in translocation for D187A and H165A, respectively.
The significantly lower translocation level of the H156A mutant suggests that the mutant
is poorly expressed and/or highly unstable in the bacterium and is quickly degraded.
Immunoblotting of the H165A mutant translocation also supports this observation (Figure
5.3). These results confirmed that the cysteine residue of the putative catalytic triad is
critical for Cif’s activity. The C109S mutant is translocated as the wild type Cif but fails
to inhibit host cell cycle progression. However, the reduced translocation of D187A and
H165A mutants prevent proper analysis of the role these residues play in Cif’s function
using the infection model.
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Figure 5.3: The secretion and translocation of Cif WT and catalytic triad mutants
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Figure 5.3: The secretion and translocation of Cif WT and catalytic triad mutants
(A) ED31 and EDL933 complemented with plasmid carrying either Cif WT or catalytic
triad mutants were grown in DMEM to activate type III secretion system. The Cif
protein was expressed with a C-terminal FLAG-tag. The pellet fraction contained the
bacteria, and the supernatant fraction contained the secreted proteins. The fractions
were resolved by SDS-PAGE and probed for Cif using anti-FLAG antibody. The
images were recomposed from the same membrane. An unknown band below Cif nonspecifically reacts in all fractions with the anti-FLAG antibody.
(B) HeLa cells were exposed 90 min to E22∆cif hosting plasmid expressing ß-lactamase
TEM-1 protein (control) or plasmid expressing translational fusion between TEM-1 and
Cif WT, mutant C109S, H165A, or D187A. Upper panel: translocation levels were
determined using CCF2-AM as a substrate for intracellular TEM-1 enzyme as described
previously (Charpentier and Oswald, 2004). Results are indicated as percentages
compared to the translocation level of Cif WT, which was set to 100%. The error bars
represent the standard error of the mean from three independent experiments. Lower
panel: the level of Cif proteins accumulated in bacteria just before the translocation
assay was detected by western-blotting analysis using anti-Cif antibodies. These
experiments were performed by Gregory Jubelin and Eric Oswald.
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5.2.3 Lipid mediated delivery of purified Cif into HeLa cells

To bypass the T3SS, translocation heterogeneity, and the need to infect cells with
bacteria, Cif WT and mutant proteins were purified and introduced into HeLa cells by
BioPORTER® (Genlantis), a lipid-mediated protein delivery agent (Taieb et al., 2006).
BioPORTER® non-covalently encapsulates protein to create a protective vehicle. The
mixture of BioPORTER® and protein is added directly to the cells, where the
BioPORTER®/protein attaches itself to the plasma membrane. The BioPORTER® fuses
with the lipid membrane and releases the protein into the cytoplasm, or the
BioPORTER®/protein mixture is endocytosed into the cell, where the protein is released
into the cytosol.
Treatment of HeLa cells with a mixture of BioPORTER® and purified Cif WT
protein resulted in cell enlargement and formation of actin stress fibers, whereas
BioPORTER® and Cif D187A induced a partial effect with both enlarged cells harboring
actin stress fibers and unaltered cells (Figure 5.4). In contrast, treatment with a mixture
of BioPORTER® and Cif C109S or H165A mutant did not affect cell morphology (Figure
5.4). Use of this alternative delivery method confirmed the inactivity of the C109S
mutant and the partial phenotype induced by the D187A mutant shown in the infection
model. In addition, these results also demonstrated the essential role of the H165 residue
since its mutation abolished the phenotype upon lipid delivery. Taken together, these
results clearly indicate that the mutation of the cysteine and histidine residues in the
putative catalytic triad completely abrogate cell cycle arrest normally
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induced by Cif and D187A to a lesser extent. These results provide strong evidence that
Cif’s catalytic triad is critical for cytotoxic activity.

Figure 5.4: Purified Cif C109S and H165A mutants do not cause cytopathic effect
HeLa cells were exposed 4 hours to the indicated proteins in combination with a
lipidic delivery agent (BioPORTER®) and further incubated 72 hours. F-actin was
stained with phalloidin-rhodamine and DNA with DAPI (blue). Bars represent 50 µm.
These experiments were performed by Gregory Jubelin and Eric Oswald.
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5.3 Cysteine protease experiments
5.3.1 Autoproteolytic activity test

Cif is structurally homologous to the cysteine protease AvrPphB. AvrPphB
triggers the hypersensitive response in plants by cleaving Arabidopsis’s protein kinase
PBS1 . But first AvrPphB must go through an autoproteolytic process to convert the
35KD precursor into a 28KD protein. The conversion is dependent on the invariant
catalytic residues (Cys98, His212, and Asp227) (Shao et al., 2002). Since AvrPphB
possesses autoproteolytic activity, Cif WT and catalytic triad point mutants were assayed
for such activity. 10µg of Cif WT and mutants were incubated in the presence and
absence of 2µM E64 and 5mM PMSF at 37°C for 24 hours. E64 is a non-competitive,
irreversible inhibitor of cysteine proteases, and PMSF inhibits a broad spectrum of serine
proteases and some cysteine proteases such as papain. Experimental data indicated that
Cif does not self-cleave at pH 8.0. Both Cif WT and mutants appear as full-length on the
SDS-PAGE gel (Figure 5.5A).
Cif could have autocatalytic activity that resembles Pseudomonas syringae
effector AvrRpt2. AvrRpt2’s predicted secondary sequence structure is similar to the
catalytic core of staphopain (Axtell et al., 2003), which is also identified as a structural
homologue of Cif by Dali (Table III). Unlike AvrPphB, AvrRpt2 undergoes autoproteolytic processing after it is translocated into the host cell. AvrRpt2 requires an
eukaryotic host factor known as cyclophilin ROC1 for the self-cleavage activity (Coaker
et al., 2005). It is possible that Cif requires a host factor(s) for self-processing. Cif ‘s
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Figure 5.5: Cif does not have autoproteolytic activity in vitro
(A) The first 4 lanes correspond to wild type Cif. The 4 terminal lanes correspond to
Cif C109S mutants. The samples were incubated at 37°C for 18 hours in the presence
and absence of protease inhibitors. Wild type Cif does not show any autoproteolytic
activity (lane WT #2)
(B) Various N-terminal His6-tagged Cif constructs were incubated with either rabbit
reticulocyte lysate (RRL) or yeast extract.
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autoproteolytic activity was tested in the presence of yeast extracts and rabbit reticulocyte
lysate.

Cif WT and mutants with N-terminal hexahistidine tag were incubated with

either yeast extract or rabbit reticulocyte lysate at 37°C for one hour and analyzed by
immunoblotting. The immunoblotting detection using anti-His(6) (Invitrogen) shows no
visible cleavage between Cif WT and mutants (Figure 5.5B).
Under the conditions tested, Cif did not exhibit autoproteolytic activity in the
presence or absence of eukaryotic proteins. Like Yersinia’s T3SS effector YopT, Cif
may not need processing to be fully functional without processing. YopT is a cysteine
protease with an invariant catalytic triad cysteine, histidine, and aspartate that cleaves
RhoA, Cdc42, and Rac at their C-termini, thus releasing them from the membrane, and
disrupting the host cytoskeleton (Shao et al., 2002; Sorg et al., 2001; Zumbihl et al.,
1999)

5.3.2 In vitro studies of Cif

The structural analysis of Cif suggested that it is a member of the cysteine
protease superfamily. We therefore attempted to demonstrate protease activity of
purified recombinant Cif in vitro. Cif, catalytic triad mutants and various N-terminal
deletion mutants were tested with a non-specific protease substrate. Casein derivative
that is labeled with the green-fluorescent BODIPY FL (Molecular Probes’ EnzChek
Protease Assay Kit) was used as a substrate to test Cif protease activity. Proteolytic
cleavage is detected by the increase in fluorescence resulting from protease cleavage of
the intramolecularly quenched substrate and releases the highly fluorescent BODIPY FL
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dye-labeled peptide. The proteolytic assay was performed as suggested by the
manufacturer. Briefly, five or ten micrograms of Cif, active site mutants, various Nterminal deletion mutants, and protease controls (papain and subtilisin) were added to
BODIPY FL casein and incubated at room temperature, protected from light, for at least
1 hour in a digestion buffer consisting of 10mM MES, pH 6.5. The detection of cleavage
products was followed by fluorescence spectrophotometry (excitation/emission:
485/530nm). HeLa extract (200µg) was also included in the assay buffer in some trials
as indicated (Figure 5.6A). Variations in pH (pH 4.2-9.0), salt concentration (0-200mM
NaCl), and additives (1mM ATP, 5mM MgCl2, or 2mM CaCl2) were screened for
optimization of the activity buffer. However, none of the assay conditions showed
evidence of protease activity in Cif. It is possible that Cif is highly specific for its
intracellular substrate and does not cleave general protease substrate like casein. As with
clostridial neurotoxins and anthrax lethal factor (Pellizzari et al., 1996; Vitale et al.,
2000), Cif could interact with specific structural motifs to recognize its substrate and
achieve full enzymatic activity.
To test whether the occluding loop could restrict accessibility to the active site,
we generated a Cif mutant lacking residues 189-195 by site-directed mutagenesis with
primers that had this region deleted. Cif Δ189-195 did not increase protease activity in
the in vitro assay (Figure 5.6B).

Treatment of HeLa cells with a mixture of

BioPORTER® and the Cif Δ189-195 mutant protein did not induce stress fibers or cell
cycle arrest (Figure 5.7A), although the poor solubility and stability of this construct
makes any interpretation of the results difficult, as the deletion likely compromised the
protein at the structural level.
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Figure 5.6: Cif does not cleave general protease substrate casein in vitro
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Figure 5.6: Cif does not cleave general protease substrate casein in vitro
(A) Cif does not possess general protease activity in vitro. Five or ten micrograms of
purified Cif constructs were incubated with BODIPY FL conjugated casein for one
hour at room temperature with or without HeLa cell extract in the buffer. The
fluorescence of BODIPY FL-labeled protease hydrolysis products was measured
(excitation/emission - 485/530nm). Five or ten micrograms of cysteine (papain) and
serine (subtilisin) proteases were included as positive controls. The error bars
represent the standard error of the mean from three independent experiments.
(B) Cif loop mutant Δ189-195 was incubated with BODIPY FL casein at various pHs.
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Figure 5.7: Cysteine protease activity is not required for the Cif induced phenotype
Cellular morphology of HeLa cells treated with BioPORTER® reagent containing either
mock (DMSO), wild type, or mutant Cif. F-actin was stained with phalloidinrhodamine (red) and DNA with DAPI (blue). Bars represent 20 µm. These experiments
were performed by Gregory Jubelin and Eric Oswald.
(A) Effect of Cif Δ189-195 loop mutant. (B) Cif pre-incubated with 70µM of the
irreversible cysteine protease inhibitor E64.

76

In a further attempt to assess protease activity of Cif, we used the cysteine
protease inhibitor E64. Addition of 70µM E64 in the mix of BioPORTER® and Cif WT
assay did not impair Cif activity (Figure 5.7B). This latter experiment suggests that
cysteine protease activity is not required for the Cif induced phenotype. E64 has been
shown to be highly specific for cysteine proteases. It is possible that Cif possesses a
cysteine protease like catalytic triad but functions like a non-protease member, such as
NAT of the cysteine protease superfamily.

5.4 Acetyltransferase activity analysis

In addition to having similarities with cysteine proteases, Cif also shares structural
homology with arylamine N-acetyltransferases. As NAT is not inhibited even with high
concentrations of E-64 or other cysteine protease inhibitors (Rodrigues-Lima et al.,
2001), this leaves open the possibility that acetyltransferase activity for Cif is responsible
for the cytopathic phenotype. For example, the Yersinia T3SS virulence effector YopJ,
long thought only to be a cysteine protease, has been shown to act as an acetyltransferase
that modulates host activity (Mukherjee et al., 2006; Orth et al., 2000).
To investigate the acetyltransferase activity of Cif, in the absence of a putative
substrate, we first examined Cif for autoacetylation activity using a radiological assay.
Cif WT or catalytic triad mutants were incubated with 14C-acetyl-CoA, and the labeling
of Cif was measured using a scintillation counter after retention on a nitrocellulose filter
(Chapter Two). 50-100µg of HeLa cell extract was included in some assays to see if
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Figure 5.8: Cif possesses acetyltransferase activity in vitro
Electrospray ionization mass spectra of wild type Cif and catalytic site mutants
incubated with acetyl-CoA. The mass colored in red in each graph corresponds to
the expected Cif mass (non-acetylated). The other peaks of Cif are separated by 42
Da and interpreted as acetylated species. (A) Wild-type Cif (B) Cif (C109S) (C)
Cif triple mutant of the active site.
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(i) Cif required host cellular factors for activity and (ii) whether Cif could cause a
detectable amount of acetylation in host proteins. Under these assay conditions, we were
unable to detect any radiolabeled Cif (data not shown).
We then used mass spectrometry, a more sensitive technique to probe Cif
autoacetylation activity. Purified Cif WT protein and C109S mutant were incubated with
acetyl-CoA and then analyzed by mass spectrometry (Figure 5.8). In the wild type Cif
protein spectrum, there were a series of peaks separated by 42 Da, that were interpreted
as multiple acetylation events, as well as a much reduced peak at a mass corresponding to
unmodified Cif (Figure 5.8A). In contrast, the catalytic triad mutant Cif C109S showed
partial acetylation activity. The main peak in its spectrum was the expected, unaltered
mass. However, there was a peak that was 42 Da larger than the expected mass, but at
much lower level than observed in the wild type protein. No evidence of poly-acetylation
was observed (Figure 5.8B). It is possible that a single point mutation from cysteine to
serine could still possess residual activity in vitro. We therefore generated a triple mutant
of Cif with two of the putative catalytic residues mutated (C109S/H165A/D187A) and
tested its auto-acetylation activity in vitro. The mass spectrum for the triple mutant had
one distinct peak corresponding to Cif’s expected mass and showed no substantial peaks
at 42 Da intervals (Figure 5.8C). Both mutants behaved identical to the wild type protein
in solution in terms of stability and solubility (data not shown). These mass spectrometry
results suggest that Cif possesses acetyltransferase activity and that mutations in the
active site reduce (Cif C109S) or abrogate (triple mutant) this auto-acetylation activity.
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CHAPTER SIX:

IDENTIFICATION OF CIF HOST TARGET

6.1 Yeast two-hybrid screening

Identifying host interaction partners for Cif should be beneficial in elucidating the
biochemical mechanism of Cif induced cell cycle arrest. Cif WT and an inactive Cif with
a mutated catalytic cysteine residue (C109S) were used for yeast two-hybrid (Y2H)
screening. The screen relies on the substrate binding to the catalytic domain of the
protease or acetyltransferase. If Cif is a cysteine protease or an acetyltransferase, then the
active Cif may cleave or acetylate the substrate before a stable interaction with the
substrate is formed. Thus, an inactive Cif can function as a trap to stably bind the
substrate without cleaving or acetylating it. Cif WT and Cif C109S mutant were cloned
into vector pB27 (LexA, C-terminal fusion) and used as bait for Y2H screening. Y2H
screenings of both human colon and placenta cDNA libraries were performed and
analyzed by HybriGenics using modified techniques as previously described (FromontRacine et al., 1997). The yeast two-hybrid screen (HybriGenics), identified Nedd8 as the
host cell interaction partner for Cif (Table IV).

6.2 Cif binds the small ubiquitin-like molecule Nedd8

A cDNA clone encoding Nedd8 (neural precursor cell expressed, developmentally
down-regulated 8) was isolated as a positive interaction partner of Cif. Nedd8 was
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Table IV: Yeast two-hybrid hits
Bait/
cDNA library

Clone Name
hgx1199 1aA-41
hgx1199 1aA-28
hgx1199 1aA-42
Cif C109S/
hgx1199 1aA-47
Colon
hgx1199 1aA-26
hgx1199 1aA-43
hgx1199 1aA-23
hgx1084v1_pB27A-19
hgx1084v1_pB27A-189
hgx1084v1_pB27A-255
hgx1084v1_pB27A-301
Cif WT/
hgx1084v1_pB27A-311
Placenta
hgx1084v1_pB27A-169
hgx1084v1_pB27A-303
hgx1084v1_pB27A-308
hgx1084v1_pB27A-109
hgx1084v1_pB27A-280
hgx1030v1_pB27A-20
Cif WT/
hgx1030v1_pB27A-2
Colon
hgx1030v1_pB27A-30

Gene
Name Start Stop
Frame Orientation
hNEDD8 -94 No Data
IF
Sense
hNEDD8 -88
277
IF
Sense
hNEDD8 3
294
IF
Sense
hNEDD8 3
294
IF
Sense
hNEDD8 3
294
IF
Sense
hNEDD8 3
294
IF
Sense
hNEDD8 4 No Data OOF1
Sense
hNEDD8 3 No Data
IF
Sense
hNEDD8 3
572
IF
Sense
hNEDD8 3
525
IF
Sense
hNEDD8 3
570
IF
Sense
hNEDD8 3
570
IF
Sense
hNEDD8 3
572
IF
Sense
hNEDD8 3
570
IF
Sense
hNEDD8 3
573
IF
Sense
hNEDD8 3
571
IF
Sense
hNEDD8 3 No Data
IF
Sense
hNEDD8 3
294
IF
Sense
hNEDD8 3
294
IF
Sense
hNEDD8 3
294
IF
Sense

identified in three Y2H screenings with different Cif constructs, first as a lower
confidence hit using the wild type protein in both human colon and placenta cDNA
libraries and then as a high confidence hit using the C109S mutant in the human colon
cDNA library (Table IV).
Nedd8 is a highly conserved 81 amino acid protein that is 60% identical and 80%
homologous to ubiquitin (Kumar et al., 1993). As with ubiquitin activation, the Cterminus of Nedd8 requires cleavage by a specific hydrolase before it can be covalently
conjugated to its substrates, the cullin family of proteins and enhance their activity
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(Lammer et al., 1998; Liakopoulos et al., 1998; Osaka et al., 1998). Cullin family
proteins are subunits of RING based E3 ubiquitin ligase complexes, which regulate the
degradation of broad range of cellular proteins. For example, the Cullin-1 associated
SCF E3 ligase is the key regulator in G1 to S transition in the cell cycle, signaling
cascades, and developmental processes (Bai et al., 1996; Dealy et al., 1999; Feldman et
al., 1997; Jiang and Struhl, 1998; Kamura et al., 1999; Skowyra et al., 1997; Yaron et al.,
1998).
To biochemically verify the genetic interaction of Cif with Nedd8 that was
observed in the yeast two-hybrid screen, we first performed a glutathione S-transferase
(GST) pulldown experiment (Chapter Two). Initially, purified GST-Cif C109S or GST
alone, acting as a control, were immobilized on a glutathione-sepharose matrix. The
proteins were then incubated with 293T cell lysate containing transient expressed Nedd8
tagged with the FLAG epitope. While the GST control did not pull out any FLAGtagged Nedd8, the GST-Cif C109S bound FLAG-tagged Nedd8 and what were interpret
to be various Nedd8 modified proteins from the 293T extract observed at higher
molecular weights (Figure 6.1A). Consistent with the yeast two-hybrid results, the
C109S mutant pulled down Nedd8 more efficiently than wild type Cif under the same
experimental conditions.
Co-expression of recombinant Cif C109S and Nedd8 protein in bacteria resulted
in the formation of a stable complex in vitro.

With bacterially co-expressed

hexahistidine-tagged Cif C109S and Nedd8, a protein complex was co-purified by nickelchelating affinity chromatography, and this complex was co-eluted using gel filtration
chromatography (Figure 6.1B). The complex is stable in salt concentrations ranging from
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0 to 200mM NaCl, but it dissociates into separate components in 500mM NaCl. The coexpression of Cif WT and Nedd8 also yields a complex, however pulls out Nedd8 less
efficiently. Furthermore, when refolding both urea denatured Cif and Nedd8, a stable
protein complex was formed that co-eluted off the gel filtration column (Figure 6.1C).
Interestingly mixing individually purified Cif with Nedd8 does not yield a protein
complex (Figure 6.1D). Cif and Nedd8 instead elute separately.
These results suggest that Cif and/or Nedd8 may need to be in a particular
conformational state prior to interaction with one another. The gradual refolding of the
two proteins together could generate intermediates in a protein conformation that is suited
for complex formation. On the other hand, the refolding of these proteins could
potentially pose a problem by forcing Cif and Nedd8 into biologically irrelevant
conformations, consequently resulting in an artificial complex. However, the coexpression of Cif and Nedd8 in a biological system, with chaperones assisting in proper
folding of the proteins, reduces the likelihood of such an event. In fact, in a bacterial coexpression system, the formation of a Cif-Nedd8 complex could be facilitated by
bacterial chaperones. The Cif-Nedd8 interaction is possibly mediated by an eukaryotic
factor in the mammalian cell.
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Figure 6.1: Cif interacts with Nedd8 in vitro
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Figure 6.1: Cif interacts with Nedd8 in vitro
(A) A GST-Cif C109S pull-down experiment using 293T cell extract expressing
FLAG-Nedd8, immunoblotted with anti-FLAG antibody. The ratio of GST/GST-Cif
C109S sample to 293T cell extract is indicated. The GST control did not pull out
FLAG-Nedd8 from the 293T extract. Using glutathione beads, GST-Cif C109S
specifically pulled out FLAG-Nedd8, and higher molecular weight neddylated
proteins, proportional to the amount of cell extract incubated in the assay.
(B) The gel filtration profile of His-Cif(23-282) in complex with Nedd8. The peak in
the chromatograph corresponds to the complex of His-Cif(23-282) and Nedd8.
Protein contents from these fractions were visualized using SDS-PAGE gels stained
with coomassie blue.
(C) The gel filtration profile of CifC109S in complex with Nedd8 after refolding. The
peak in the chromatograph corresponds to the complex of CifC109S and Nedd8.

The

peak at 45ml elution volumeProtein contents from these fractions were visualized
using SDS-PAGE gels stained with coomassie blue.
(D) The gel filtration profile of CifC109S mixing with Nedd8. The peaks in the
chromatograph correspond to CifC109S and Nedd8. Protein contents from these
fractions were visualized using SDS-PAGE gels stained with coomassie blue.
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6.3 Cif N-terminal domain is involved in Nedd8 interaction

Once the binding interaction between Cif and Nedd8 was established, we sought
to determine which Cif domain interacted with Nedd8. The N-terminal hexahistidine
tagged Cif23-99 or Cif100-282 and Nedd8 were co-expressed in bacteria from a
bicistronic plasmid (Chapter Two). The proteins were loaded onto nickel-chelating
sepharose to immobilize the hexahistidine tagged Cif and eluted with imidazole wash.
The bacterial co-expression trials revealed that the crystallized, protease/acetyltransferase
homology domain (100-282) does not bind Nedd8 on its own, whereas an N-terminal
peptide spanning residues 23-99 was able to pull down Nedd8 and co-elute on a gel
filtration column (Figure 6.3A). This was an interesting finding, suggesting that the Nterminal domain of Cif was critical to the Nedd8 interaction. To ascertain the importance
of the N-terminal domain in the cytopathic phenotype, we delivered an N-terminal
deletion construct (100-282-His) into HeLa cells using BioPORTER®. This Cif construct
was unable to induce cell cycle arrest or stress fiber formation and was indistinguishable
from untreated, control cells (Figure 6.3B). Cif’s C-terminal domain, containing the
active catalytic triad, is therefore not sufficient to induce the cytopathic effect. These
findings suggest that Cif’s N-terminal domain is functionally important for substrate
binding and/or recognition, whereas the C-terminal domain is critical for enzymatic
activity.
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Figure 6.2: The N-terminal domain is required for Cif activity and binds the host
protein Nedd8
(A) His-Cif(23-99)/His-Cif(100-282) pulldown on nickel-chelating sepharose of
Nedd8 visualized using SDS-PAGE gel stained with coomassie blue. His-Cif(2399)/His-Cif(100-282) were bacterially co-expressed with Nedd8.
(B) The N-terminal domain (30-99) of Cif is required for CPE induction. HeLa cells
were exposed 4 hours with the indicated purified Cif protein or PBS (control) in
combination with the lipid delivery agent (BioPORTER®) and were further incubated
72 hours. F-actin was stained with phalloidin-rhodamine (red) and DNA with DAPI
(blue). Bars correspond to 20 µm. These experiments were performed by Gregory
Jubelin and Eric Oswald.
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6.4 Cif does not cleave/acetylate Nedd8 or neddylated Cullin-1

The yeast two-hybrid results, the GST pull-down and co-expression experiments,
and the established importance of Cif’s N-terminal domain for the cytopathic phenotype,
all provided evidence for Nedd8 playing an important role in Cif’s ability to deregulate
the eukaryotic cell cycle. Cif could modulate the cell cycle by sequestering, inhibiting, or
activating Nedd8. Thus, we first examine whether Cif could proteolytically cleave
Nedd8. Extensive incubations of Cif and GST tagged Nedd8 did not detect any such
degradation (data not shown). Cif could also function as a deneddylase, a specific
protease, similar to DEN1/NEDP1 that hydrolyzes Nedd8 at a C-terminal Gly-Gly
dipeptide, transforming it into a mature conjugable protein (Gan-Erdene et al., 2003;
Hochstrasser, 1998; Mendoza et al., 2003; Wu et al., 2003b). To assess whether Cif
cleaves Nedd8, we used the substrate Nedd8-AMC, with a

C-terminal

amidomethylcoumarin, in order to monitor the cleavage reaction (Figure 6.4A). Since
Nedd8 shares structural and sequence homology to ubiquitin and SUMO (a ubiquitin-like
protein), Cif’s activity on ubiquitin-AMC and SUMO-AMC were also examined (Figure
6.4B). Recombinant Cif did not cleave the AMC moiety off any of the ubiquitin-like
proteins in this assay while the deneddylase NEDP1 actively cleaved Nedd8 at the Cterminus, releasing the AMC moiety into solution. NEDP1 did not cleave ubiquitin or
SUMO indicating this protease exhibits high substrate specificity.
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Figure 6.3: Cif does not hydrolyze ubiquitin-like proteins at their C-terminus
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Figure 6.3: Cif does not hydrolyze ubiquitin-like proteins at their C-terminus
(A) The ability of Cif WT, Cif C109S, and NEDP1 to perform Nedd8-AMC
hydrolysis. Both CifWT and Cif C109S did not cleave Nedd8 at the C-terminus. The
deneddylase enzyme, NEDP1, was able to hydrolyze Nedd8-AMC at the C-terminus,
yielding a fluorescence signal.
(B) The ability of various Cif constructs to perform ubiquitin-like protein-AMC
(ULPs) hydrolysis. The Cif proteins were incubated with ubiquitin-AMC, Nedd8AMC, or SUMO-AMC. Cif did not cleave any of the ULPs at the C-terminus.
NEDP1 was highly specific for Nedd8.
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Figure 6.4: Cif does not possess in vitro deneddylation activity for Cul1,
APPBP1/UBA3, or Ubc12
(A) Deneddylation of neddylated Cul1. Cif WT, Cif C109S, or NEDP1 was incubated
with neddylated Cullin-1 at 37°C for 2 hours. The samples were separated by SDSPAGE and immunoblotted with anti-Nedd8 antibody. Unlike the NEDP1 control,
neither Cif WT nor Cif C109S reduces the amount of neddylated Cul1 in the reaction.
(B) Cif was incubated in the neddylation reaction that included APPBP1/UBA3, Ubc12,
and Cul1. Cif did not have an inhibitory effect on E1 activating or E2 conjugating
activity, whereas NEDP1 successfully inhibited Cul1 neddylation. Cif proteins crossreacted with the rabbit anti-Nedd8 antibody (Alexis).
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Another possible mode of action for Cif is that it only cleaves Nedd8 from Nedd8
conjugated proteins. We reconstituted one well-studied neddylated substrate, Cul1 of the
SCF complex, in vitro to assay for such activity. The neddylation of Cul1 is a complex
reaction that requires the activities of various enzymes: the E1 activating enzyme
APPBP11/UBA3, the E2 conjugating enzyme Ubc12, and the SCF subunit Rbx1. The
reconstitution of neddylated Cul1 is described in Chapter Two. Neddylated Cul1 in the
SCF complex was incubated with either Cif WT or Cif C109S. We did not observe a
decrease in the amount of neddylated Cul1 in the reaction containing Cif WT, whereas
the control hosting deneddylase NEDP1 was very active in doing so (Figure 6.5A). To
see whether Cif has an inhibitory effect on the neddylation of Cul1 by acting on either the
E1 or E2 enzyme, Cif was incubated in the Cul1 neddylation assay. As shown in Figure
6.5B, Cul1 was poly-neddylated despite the presence of Cif. Cif does not inhibit E1’s
Nedd8 activating activity or E2’s conjugating activity on Cul1. Meanwhile, NEDP1
successfully prevents the Nedd8 conjugation of Cul1. Finally, given our results that Cif
possesses acetyltransferase activity, we examined whether Cif acetylates Nedd8. Cif,
acetyl-CoA, and Nedd8 were co-incubated, and the mixture was sent for mass
spectrometry analysis. The mass spectrum showed no evidence of Nedd8 acetylation
(Figure 6.6).
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Figure 6.5: Cif does not acetylate Nedd8 in vitro
Electrospray ionization mass spectrum of Nedd8 after incubation with Cif WT and
acetyl-CoA.

Even though Cif does not cleave or acetylate Nedd8 under our assay conditions,
Cif binds Nedd8 with its N-terminal domain, not its catalytic C-terminal domain. It is
therefore possible that Cif does not directly act on Nedd8, but instead on Nedd8
associated proteins. This hypothesis was tested by incubating Cif with neddylated Cul1.
No change in Cul1’s neddylation pattern was observed. This does not eliminate the
possibility that Cif interacts with other members of the cullin family (Cullin 2, 3, 4a/b, 5,
6, 7, 8, and Parc) or other yet to be identified Nedd8 modified proteins.
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CHAPTER SEVEN:

CONCLUSIONS

Bacterial pathogens utilize a wide array of virulence factors to modulate host cell
biochemistry. In particular, the protein substrates of T3SS possess remarkable properties
that alter the host cytoskeleton, signal transduction pathways, cell cycle progression, and
programmed cell death (Galan and Cossart, 2005). One of these translocated effectors,
Cif, from pathogenic E. coli strains is associated with a cytopathic effect involving cell
cycle arrest and cell distension (Marches et al., 2003). The molecular basis for this
activity has remained elusive. Though not all pathogenic E. coli strains harbor the cif
gene, Cif could be advantageous for bacteria in two ways. First, Cif’s perturbation of
host cellular processes could prolong bacterial colonization by blocking mitosis, which
results in the disruption of intestinal epithelium integrity. Second, Cif could possibly
impair the immune system by inhibiting clonal expansion of lymphocytes (Cortes-Bratti
et al., 2001; Gelfanova et al., 1999; Shenker et al., 2001). Furthermore, with the
capability of the cif-encoding lambdoid prophage from E. coli E22 to propagate to new
strains by lysogenic conversion in vitro (Loukiadis et al., 2008), it is possible for strains
lacking cif, such as the deadly E. coli O157:H7, to acquire such a virulent attribute.
The Cif crystal structure presented here shows that this T3SS substrate is a
divergent member of the cysteine protease superfamily. Cif possesses a conserved core
fold containing a putative catalytic triad composed of cysteine, histidine, and glutamine,
which aligns well with the catalytic triads of other cysteine proteases and
acetyltransferases. It is the first member from its superfamily to possess glutamine as its
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third catalytic residue instead of the typical aspartate or asparagine. Mutation of any of
these residues results in a Cif molecule that cannot induce cell cycle arrest during
infection or when introduced exogenously into cells.
Given its structural resemblance to both cysteine proteases and acetyltransferases,
Cif may possess either protease activity or acetyltransferase activity. In fact, as has been
shown to be the case with the Yersinia effector YopJ (Mukherjee et al., 2006; Orth et al.,
2000), it could very well possess both activities. To date, we have been unable to show
protease activity of purified recombinant Cif in vitro. Cif might possess such a high
specificity for its intracellular substrate that it does not cleave a general protease substrate
in an in vitro assay. On the other hand, as with clostridial neurotoxins and anthrax lethal
factor (Pellizzari et al., 1996; Vitale et al., 2000), Cif could interact with a specific
structural motif to fully engage its substrate. It is also possible that full-length Cif could
be inactive (as a zymogen) and thus requires a eukaryotic host factor for activation
through processing or modification. Such activation could resemble that of the autoproteolytic activity of the Pseudomonas syringae effector AvrRpt2, which requires the
eukaryotic host factor cyclophilin to induce self-cleavage (Coaker et al., 2005). A unique
structural feature to Cif within the cysteine protease superfamily is a loop that occludes
part of the active site. It is conceivable that interaction with and/or modification by
eukaryotic partner(s) could induce conformational changes allowing more efficient
access of the substrate to the catalytic site. On the other hand, Cif may only possess
acetyltransferase activity. Cif’s activity is not affected by the cysteine protease inhibitor
E64, suggesting that the Cif-induced phenotype does not require the activity of a cysteine
protease. Cif could also utilize a common catalytic mechanism from cysteine proteases
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to accommodate it own enzymatic mechanism. Our results show that it is able to autoacetylate in vitro, and that this activity is tied directly to the active site triad.
The identification of the host cellular targets for Cif will provide the direct means
to examine the enzymatic activities suggested by the structure. Towards these efforts, we
identified the small, ubiquitin-like molecule Nedd8 as a potential Cif host-binding
partner. Nedd8 is a key regulator of host cell cycle progression. It is covalently attached
to Cullin-1 of the SCF complex. Given the central role of the SCF complex in cell cycle
regulation and the large number of SCF substrates, Cif could act on any of the SCF
substrates through its interaction with Nedd8. Our biochemical findings indicate that
Nedd8 and Cif do interact to form a stable protein complex. In particular, the N-terminal
domain seems to be the stronger contributor to Nedd8 binding. Intriguingly, the Nterminal domain is also absolutely required for the Cif-induced cytopathic effect,
showing that both domains of Cif are critical to the function of this virulence factor in the
host cell. We speculate that Cif subverts the cellular neddylation machinery to facilitate
bacterial colonization.
Currently, our data has not demonstrated any proteolytic activity of Cif on Nedd8
or neddylated Cullin-1. The lack of any detectable enzymatic activity of Cif toward
Nedd8 raises the question of what biological function this interaction possesses. Instead
of being a direct substrate, Nedd8 could act as an allosteric activator of Cif. For example,
Nedd8 could bind Cif and cause a conformational change in the occluding loop that
opens the active site for substrate binding. In addition, Nedd8 could simply serve as a
targeting protein, bringing Cif to other proteins in the SCF complex or other cullin related
complexes. For instance, there is evidence for the accumulation of p21 in cells that are
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infected with Cif (personal communication with E. Oswald). p21 is a Cdk inhibitor that
prevents cells from progressing into S phase. p21 is ubiquitylated by the SCF complex
and then targeted for 26S Proteasome for degradation.

Cif could prevent the

ubiquitylation of p21 by interacting with any components of the SCF complex via Nedd8.
In summary, Cif belongs to a superfamily of enzymes that includes cysteine
proteases and acetyltransferases. Both types of enzymes have been shown to function in
bacterial pathogenesis. Mutagenesis of the predicted catalytic triad residues in Cif results
in the loss of host cell cycle arrest normally induced by the pathogen, linking the
proposed protease or acetyltransferase function from the crystal structure to the
cytopathic phenotype. Future studies will focus on finding the host cell substrate(s) for
Cif (enzymatic activity) and elucidating its functional role in causing cytopathic effects.
Understanding how Cif is able to modulate the host cell cycle for the benefit of the
pathogen may also give a new perspective on the mechanisms of host cell cycle
regulation.
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